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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
 
 
 
 
 
 
 
 
 
 
 
 
Steering Group of the evaluation 
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Panel members 
CHAIR 
Professor Lorenz Poellinger 
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Karolinska Institute, Sweden 
 
VICE-CHAIR 
Professor Cornelia van Duijn 
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Erasmus Medical Centre, the Netherlands 
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Molecular cell biology, cell adhesion, cancer biology 
University of Turku, VTT Technical Research Centre, Finland 
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University of Turku, Finland 
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Karolinska Institute, Sweden 
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The panel, independently, evaluated all the submitted material and was responsible for the 
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discussion and report writing. 
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providing the evaluation project with the updated information from TUHAT-RIS. 
The TUHAT office assisted in mapping the publications with CWTS/University of 
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MA Liisa Ekebom, Assisting Officer, served in TUHAT-RIS updating the 
publications for the evaluation. She also assisted the UH/Library analyses. 
BA Liisa Jäppinen, Assisting Officer, served in TUHAT-RIS updating the 
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3 
 
 
Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
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1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
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4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
 
 
13 
 
1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
The RC “Neuroiontroph” is based on the Finnish Centre of Excellence in “Molecular and Integrative 
Neuroscience Research” (2008-2013), comprised of initially seven research groups (Saarma, Kaila, Rivera, 
Arumäe, Rauvala, Castrén, Airaksinen), of which the latter three have joined the RC “Neuron”, and more 
recently two groups have been added (Goldman, Voipio). The strengths of the RC rely on a clear scientific 
focus on neurotrophic factors and their crosstalk with ion regulatory proteins, and a critical mass of 
excellent researchers and broad technical expertise, which together have enabled interdisciplinary 
approaches from resolving protein structures via characterization of physiological mechanisms to clinical 
application. These elements have been strategically assembled by the founders of “Neuroiontroph” and 
complemented by dedicated Master’s and Doctoral Programs (see pt. 2.2). 
Neurotrophic factors and ion regulatory proteins are key to neural development, plasticity and 
functional restitution after injury or degeneration. The RC has an outstanding expertise to address the 
underlying molecular mechanisms and therapeutical potential. The approaches are convincingly 
complementary, both in scientific and technical terms. 
The scientific quality of Neuroiontroph is outstanding by international standards, with respect to 
scientific output and input (see pt. 2.7). The science of the NC is highly original and innovative. Scientific 
findings of the NC have significantly contributed to setting the pace of the research field, and in parts have 
led to remarkable clinical translations. One landmark finding by the group of Saarma is the discovery of 
CDNF, a novel neurotrophic factor with neuroprotective function in models of Parkinson’s disease with and 
high therapeutical potential. The overall output of NC is indicative of the outstanding quality (rather than 
quantity), with an average of around 25 publications/year, all in competitive and very good journals, and 
an impressive number (30%) in top-rank journals of Neuroscience and in interdisciplinary journals. This 
distribution indicates the strategy of Neuroiontroph for high quality output, and unequivocally supports 
the mission of striving after quality rather than quantity already at the doctoral training level (see pt. 2.8). 
The Neuroiontroph overall concept is successfully synergistic, as indicated by numerous common 
publications, and the strategic development of the research groups. Moving of Rauvala, Castrén, 
Airaksinen to Neuron, in view of the focus mostly on synaptic plasticity, and adding Goldman, Voipio, with 
a focus on X-ray crystallography and systems neuroscience, respectively, seems a very wise strategic 
decision. This step will complement the RC expertise by a) structure determination and interaction studies 
of the molecules, and b) functionally oriented studies with respect to systems relevance (see pt. 2.8). 
Planned collaboration with the RC PDBD (Tuominen) on pharmacological interference approaches 
(Tuominen), developing ki and ko technologies and in vivo two photon image analyses seems a good 
interdisciplinary investment. Overall, the concept with one RC (Neuroionotrop) focusing on neurotrophic 
molecules and interacting molecules, one (Neuron) focusing on the mechanisms of synaptic plasticity, and 
one (PDBD) on pharmacological aspects of frequent neurodegenerative diseases, is certainly unique, and 
puts Helsinki University in a position of discovering and developing novel medical treatments of a 
worldwide impact (see pt. 2.3). It is highly recommended that these strategies are further pursued and 
strengthened. 
Numeric evaluation: 5 (Outstanding) 
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2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
It is particularly impressive to see the wide range of high quality program elements and the well-
balanced measures of quality assurance: there are few curricula of this kind in neuroscience worldwide. 
Doctoral students can choose from three local doctoral programs (Finnish Grad School of Neuroscience; 
Helsinki Grad School of Biotech and Mol Biol, Program in Informational and Structural Biol). The tools for 
quality assurance include competitive open calls, ranking upon clear criteria, thesis committees, high 
quality teaching programs, monthly CoE seminars, weekly Neurosci seminars, and international exchange. 
Furthermore, Neuroiontroph researches have been actively setting up masters’s level training in 
neuroscience and biotechnology, and participate to international networks of doctoral programs (EU Marie 
curie, TEMPUS). 
Neuroiontroph researchers have been supervising a total of 42 doctoral thesis 2005–2010, which is a 
fair effort for an institution of the size of Neuroiontroph (also indicating the strive for quality rather than 
quantity). It is an impressive example on how human resources/potential can be linked to scientific 
excellence, and there is no doubt that graduates will make their way in science. It would be interesting to 
obtain a more systematic follow-up survey of the graduates. 
The recent (2010) initiative for a Doctoral Program in Brain and Mind (DPBM) is a great asset towards 
merge the various doctoral training programs. It would be interesting to see, if PhD requirements are 
harmonized between participating universities (Helsinki, Aalto) and faculties. Furthermore, the respective 
PIs and Helsinki University may consider further investing into a dedicated MD/PhD program. 
Numeric evaluation: 5 (Outstanding) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The societal impact of Neuroiontroph resides in the identification of neurotrophic factors that are key to 
development, function and dysfunction of the brain. Key findings of CDNF have been patented and given 
rise to a spin-off company, GDNF variants are tested in models of Parkinson’s disease, novel variants of 
NTF with improved pharmacokinetics have been synthesized, and translational studies are carried out in 
experimental models and temporal lobe epilepsy patients involving novel/innovative treatment principles 
related to CO2 regulation. The number of patents (5 patent families, 12 patent applications) and licensing 
agreement is very impressive and indicative of the outstanding societal relevance of the PI’s research. The 
Neurodegenerative initiative (Saarma) linking the 25 best research groups in the field of neuroscience 
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(Helsinki University, Univ Eastern Finland), the City of Helsinki and Sitra, and biotech and pharmaceutical 
companies, is apt to further strengthen translational and commercialization routes. 
As a corollary, the PIs of Neuroiontroph have actively and intensively promoted visibility of 
neuroscience by numerous public activities. 
Numeric evaluation: 5 (Outstanding) 
2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
The excellent scientific reputation of Neuroiontroph is reflected by an exceptionally high proportion of 
staff members from foreign countries (50%), its contribution to several international research networks 
established after competitive evaluation (EU FP6 EPICURE, EU FP7 NEMO), memberships of numerous 
editorial boards of international scientific journals, and continued invitation for review articles in most 
prestigious international journals. The Neuroscience Graduate Program and Master’s program are parts of 
the CORTEX training network (EU Marie curie), and the Network of European Neuroscience Schools 
(NENS), respectively. 
Establishment of an international Scientific Advisory Board for assuring quality control is appreciable, 
although the PIs might consider increasing the number of members of the SAB (currently 2) in order to 
more fully reflect the range of expertise of Neuroiontroph. Overall, Neuroiontroph can certainly be viewed 
as being an international research and teaching organization. 
Given the limited human resources of the Finnish academic system, Neuroiontroph should consider 
foreign recruitment on a more systematic basis. Seeking the contact of foreign offices of granting 
agencies, Neuroscience or Biomedical societies, or other Neuroscience Centres might be a promising way. 
Numeric evaluation: 5 (Outstanding) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
Research environment and technical infrastructure, including the core facilities at Viikki, the Institute of 
Biotechnology and the Neuroscience Centre, seem to be excellent. The recent extension of Xray 
crystallography, in vivo microscopical imaging and electrophysiology facilities, electroporation/cell 
culture facilities, electron tomography, and SPECT-CD will make an important complementary contribution 
(see pt. 2.1).With respect to animal facilities, Helsinki University should undertake all necessary steps for 
improvement of the current state, finalize the central animal facility and provide adequate animal 
facilities/experimental labs for in vivo studies. 
Information on teaching duties cannot be deduced from available data. 
A major challenge seems to be the overall shortage of basic funding in Finland, hampering recruitment 
of good people, of maintenance of core facilities and of providing reliable infrastructural conditions. The 
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situation should be critically evaluated, and improved as necessary. This seems particularly justified in 
view of the limited personnel resources of Finland, which requires international recruitments, and 
strategies to succeed in this competition for the best. Only through recruitment of the best can the 
outstanding research of Neuroionotroph be sustained. 
2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The organizational structure goes along a rather traditional route, and there seems to be no need for a 
change (see pt. 2.1, 2.2, 2.5). 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005– 31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005– 31.12.2010. 
 Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
Extra-mural funding amounts to a total of appr 14.2 Mill € (appr 2.5 Mill € p.a.), including national and 
international (EU) funds. This marks an excellent value. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
The RC’s future strategy builds on the status quo and indicates four general aspects for future 
improvement: research quality, translational efforts, doctoral training and promotion of female 
researchers. No specific ideas are described and in fact are not needed: it is clear that the main strength of 
the RC is a critical mass of scientific excellence in an important field in neuroscience with high societal 
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impact, and a broad technical competence, thereby enabling analyses from structural biology to the 
organism level and close collaboration with industry and clinics. This is overall convincing. Given the pre-
existing excellence, and continued and extended support of Helsinki University, the continued success of 
RC in scientific and academic terms is foreseeable, and apt to improve the visibility of Helsinki University 
on the map of biochemistry/molecular biology, biotechnology and neuroscience. 
2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 4. The research of the participating community represents an innovative opening. 
 
There is no doubt that research of the Neuroiontroph community marks an innovative field of high 
translational potential. The program reflects the international status and peer-recognition, the RC has 
made an outstanding contribution to the field of neuroscience, and overall represents the international 
cutting edge in this field. 
Numeric evaluation: 5 (Outstanding) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The processes employed were fair and appropriate. 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 2: The basic structure of life 
 
For details, see pt. 2.6 above. Overall, Neuroiontroph is central to the UH’s focus on “Basic Structure of 
Life”, and it creates a significant part of the biomedical profile of UH. 
2.12 RC-specific main recommendations 
Given the pre-existing excellence, the continued success of the RC in scientific and academic terms is 
foreseeable, and apt to improve the visibility of Helsinki University on the map of biochemistry/molecular 
biology, biotechnology and neuroscience. Therefore, specific recommendations are not needed at this 
point, other than the continued and extended support of Helsinki University. A major challenge seems to 
be the overall shortage of basic funding, hampering recruitment of good people, of maintenance of core 
facilities and of providing reliable infrastructural conditions. The situation should be critically evaluated, 
and improved as necessary. 
2.13 RC-specific conclusions 
The strengths of the RC Neuroiontroph rely on a clear scientific focus on neurotrophic factors and their 
crosstalk with ion regulatory proteins, and a critical mass of excellent researchers and broad technical 
expertise, which together have enabled interdisciplinary approaches from resolving protein structures via 
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characterization of physiological mechanisms to clinical application at an international top level. Research 
environment and technical infrastructure seem to be excellent. 
These elements have been strategically assembled by the founders of “Neuroiontroph”, and 
complemented by dedicated Master’s and Doctoral Programs. The wide range of high quality program 
elements and the well-balanced measures of quality assurance are particularly impressive: there are few 
curricula of this kind in neuroscience worldwide. The societal impact of Neuroiontroph is very high, 
residing in the identification of neurotrophic factors that are key to development, function and dysfunction 
of the brain. 
There is no doubt that research of the Neuroiontroph community marks and innovative field of high 
translational potential. The program reflects the international status and peer-recognition, the RC has 
made an outstanding contribution to the field of neuroscience and overall represents the international 
cutting edge in this field. 
The greater concept with one RC (Neuroionotrop) focusing on neurotrophic molecules and interacting 
molecules, one (Neuron) focusing on the mechanisms of synaptic plasticity, and one (PDBD) on 
pharmacological aspects of frequent neurodegenerative diseases, is certainly unique, and puts Helsinki 
University in a position of discovering and developing novel medical treatments of a worldwide impact. It 
is highly recommended that these strategies are further pursued and optimally supported by Helsinki 
University. 
2.14 Preliminary findings in the Panel-specific feedback 
— 
2.15 Preliminary findings in the University-level evaluation 
Research Focus 
The RC “Neuroiontroph” is based on the Finnish Centre of Excellence in “Molecular and Integrative 
Neuroscience Research” (2008–2013), comprised of initially seven research groups (Saarma, Kaila, Rivera, 
Arumäe, Rauvala, Castrén, Airaksinen), of which the latter three have joined the RC “Neuron”. More 
recently, two groups (Goldman, Voipio) have been added to the consortium. The strengths of the RC rely 
on a clear scientific focus on neurotrophic factors and their crosstalk with ion regulatory proteins, and a 
critical mass of excellent researchers and broad technical expertise which have enabled interdisciplinary 
approaches from resolving protein structures via characterization of physiological mechanisms to clinical 
application. These elements have been strategically assembled by the founders of “Neuroiontroph”, and 
complemented by dedicated Master’s and Doctoral Programs (see below). 
Neurotrophic factors and ion regulatory proteins are key to neural development, plasticity and 
functional restitution after injury or degeneration. The RC has an outstanding expertise to address the 
underlying molecular mechanisms and therapeutical potential. The approaches are convincingly 
complementary, both in scientific and technical terms. 
The scientific quality of Neuroiontroph is outstanding by international standards, with respect to 
scientific output and input (see below). The science of the NC is highly original and innovative. Scientific 
findings of the NC have significantly contributed to setting the pace of the research field, and in parts have 
led to remarkable clinical translations. One landmark finding by the group of Saarma is the discovery of 
CDNF, a novel neurotrophic factor with neuroprotective function in models of Parkinson’s disease with 
high therapeutic potential. The overall output of NC is indicative of the outstanding quality (rather than 
quantity), with an average of around 25 publications/year, all in competitive and very good journals, and 
an impressive number (30%) in top-rank journals of Neuroscience and in interdisciplinary journals. This 
distribution illustrates the strategy of Neuroiontroph for high quality output, and unequivocally supports 
the mission of striving after quality rather than quantity already at the doctoral training level. 
The Neuroiontroph overall concept is successfully synergistic, as indicated by numerous common 
publications, and the strategic development of the research groups. Moving of Rauvala, Castrén, 
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Airaksinen to Neuron, in view of the focus mostly on synaptic plasticity, and adding Goldman, Voipio, with 
a focus on X-ray crystallography and systems neuroscience, respectively, seems a very wise strategic 
decision. This step will complement the RC expertise by a) structure determination and interaction studies 
of the molecules, and b) functionally oriented studies with respect to systems relevance. The planned 
collaboration with the RC PDBD (Tuominen) on pharmacological interference approaches (Tuominen), 
developing ki and ko technologies and in vivo two photon image analyses seems to be a good 
interdisciplinary investment. Overall, the concept with one RC (Neuroionotrop) focusing on neurotrophic 
molecules and interacting molecules, one (Neuron) focusing on the mechanisms of synaptic plasticity, and 
one (PDBD) on pharmacological aspects of frequent neurodegenerative diseases, is certainly unique, and 
puts Helsinki University in a position of discovering and developing novel medical treatments of a world-
wide impact. It is highly recommended that these strategies are further pursued and strengthened. 
 
Practices and Quality of Doctoral Training 
It is particularly impressive to see the wide range of high quality program elements and the well-balanced 
measures of quality assurance: there are few curricula of this kind in neuroscience worldwide. Doctoral 
students can choose from three local doctoral programs (Finnish Grad School of Neuroscience; Helsinki 
Grad School of Biotech and Mol Biol, Program in Informational and Structural Biol). The tools for quality 
assurance include competitive open calls, ranking upon clear criteria, thesis committees, high quality 
teaching programs, monthly CoE seminars, weekly Neurosci seminars, and international exchange. 
Furthermore, Neuroiontroph researches have been actively setting up Masters’s level training in 
neuroscience and biotechnology, and participate to international networks of doctoral programs (EU Marie 
curie, TEMPUS). 
Neuroiontroph researchers have been supervising a total of 42 doctoral theses 2005–2010, which is a 
fair effort for an institution of the size of Neuroiontroph (also indicating the strive for quality rather than 
quantity). It is an impressive example on how human resources/potential can be linked to scientific 
excellence, and there is no doubt that graduates will make their way in science. It would be interesting to 
obtain a more systematic follow-up survey of the graduates. 
The recent (2010) initiative for a Doctoral Program in Brain and Mind (DPBM) is a great asset toward 
merging the various doctoral training programs. It would be interesting to see if PhD requirements are 
harmonized between participating universities (Helsinki, Aalto) and faculties. Furthermore, the respective 
PIs and Helsinki University may consider further investing into a dedicated MD/PhD program. 
 
Societal Impact 
The societal impact of Neuroiontroph resides in the identification of neurotrophic facors that are key to 
development, function and dysfunction of the brain. Key findings of CDNF have been patented and given 
rise to a spin-off company, GDNF variants are tested in models of Parkinson’s disease, novel variants of 
NTF with improved pharmacokinetics have been synthesized, and translational studies are carried out in 
experimental models and temporal lobe epilepsy patients involving novel/innovative treatment principles 
related to CO2 regulation. The number of patents (5 patent families, 12 patent applications) and licensing 
agreement is very impressive and indicative of the outstanding societal relevance of the PI’s research. The 
Neurodegenerative initiative (Saarma) linking the 25 best research groups in the field of neuroscience 
(Helsinki University, Univ Eastern Finland), the City of Helsinki and Sitra, and biotech and pharmaceutical 
companies, is apt to further strengthen translational and commercialization routes. 
As a corollary, the PIs of Neuroiontroph have actively and intensively promoted visibility of 
neuroscience by numerous public activities. 
 
International and National Collaboration 
The excellent scientific reputation of Neuroiontroph is reflected by an exceptionally high proportion of 
staff members from foreign countries (50%), its contribution to several international research networks 
established after competitive evaluation (EU FP6 EPICURE, EU FP7 NEMO), memberships of numerous 
editorial boards of international scientific journals, and continued invitation for review articles in most 
prestigious international journals. The Neuroscience Graduate Program and Master’s program are parts of 
22 
 
the CORTEX training network (EU Marie curie), and the Network of European Neuroscience Schools 
(NENS), respectively. 
Establishment of an international Scientific Advisory Board for assuring quality control is 
commendable, although the PIs might consider increasing the number of members of the SAB (currently 
2) in order to more fully reflect the range of expertise of Neuroiontroph. Overall, Neuroiontroph can 
certainly be viewed as being an international research and teaching organization. 
Given the limited human resources of the Finnish academic system, Neuroiontroph should consider 
foreign recruitment on a more systematic basis. Seeking the contact of foreign offices of granting 
agencies, Neuroscience or Biomedical societies, or other Neuroscience Centres might be a promising way. 
 
Leadership and Management 
The organizational structure goes along a rather traditional route, and there seems to be no need for 
changes or improvements. 
 
External Funding 
Extra-mural funding is impressive amounting to a total of appr 14.2 Mill € (appr 2.5 Mill € p.a), including 
national and international (EU) funds. 
 
Strategic Action Plan 
The RC’s future strategy builds on the status quo, and indicates four general aspects for future 
improvement: research quality, translational efforts, doctoral training and promotion of female 
researchers. No specific ideas are described and in fact are not needed: it is clear that the main strength of 
the RC is a critical mass of scientific excellence in an important field in neuroscience with high societal 
impact, and a broad technical competence, thereby enabling analyses from structural biology to the 
organism level and close collaboration with industry and clinics. This is overall convincing. Given the pre-
existing excellence, and continued and extended support of Helsinki University, the continued success of 
the RC in scientific and academic terms is foreseeable, and apt to improve the visibility of Helsinki 
University on the map of biochemistry/molecular biology, biotechnology and neuroscience. 
 
Conclusions and Recommendations 
The strengths of the RC “Neuroiontroph” rely on a clear scientific focus on neurotrophic factors and their 
crosstalk with ion regulatory proteins, and a critical mass of excellent researchers and broad technical 
expertise, which together have enabled interdisciplinary approaches from resolving protein structures via 
characterization of physiological mechanisms to clinical application at an international top level. The 
research environment and technical infrastructure seem to be excellent. These elements have been 
strategically assembled by the founders of “Neuroiontroph”, and complemented by dedicated Master’s 
and Doctoral Programs. The wide range of high quality program elements and the well-balanced measures 
of quality assurance are particularly impressive: there are few curricula of this kind in neuroscience 
worldwide. The societal impact of Neuroiontroph is very high, residing in the identification of neurotrophic 
factors that are key to development, function and dysfunction of the brain. 
There is no doubt that research of the Neuroiontroph community marks an innovative field of high 
translational potential. The program is of high international status, and the RC has made an outstanding 
contribution to the field of neuroscience. Overall, it represents the international cutting edge in this field. 
The greater concept with one RC (Neuroionotrop) focusing on neurotrophic molecules and interacting 
molecules, one (Neuron) focusing on the mechanisms of synaptic plasticity, and one (PDBD) on 
pharmacological aspects of frequent neurodegenerative diseases, is certainly unique, and puts Helsinki 
University in a position of discovering and developing novel medical treatments of a worldwide impact. It 
is highly recommended that these strategies are further pursued and optimally supported by Helsinki 
University. 
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3 Appendices 
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a. Registration material – Stage 1 
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d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
 
 
 
 
 
International evaluation of research and doctoral training 
at the University of Helsinki 2005-2010 
 
         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Molecular and Integrative Neuroscience Research (Neuroiontroph) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Academy Professor Mart Saarma, Institute of Biotechnology 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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Name: Saarma, Mart 
E-mail:  
Phone: 09-19159378 
Affiliation: Institute of Biotechnology 
Street address: Viikinkaari 9 (P.O.Box 56) 
 
 
Name of the participating RC (max. 30 characters): Molecular and Integrative Neuroscience Research 
Acronym for the participating RC (max. 10 characters): Neuroiontroph 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): This RC is based on the 
Finnish Centre of Excellence in Molecular and Integrative Neuroscience Research “Trophic factors in 
neuronal development, plasticity and disease”, 2008-2013. The original CoE consists of 7 groups, but the 
groups of Prof. Rauvala, Prof. Castrén and Dr. Airaksinen will join the RC of the Neuroscience Center.  Our 
RC is focusing on the neurotrophic factors and their cross talk with ion regulatory proteins in development, 
plasticity and disease. We cover neurobiology starting from the atomic structures to clinical studies. The 
key elements of our research are the application of the results and translational studies. To strengthen the 
structural studies on therapeutically important neurotrophic factors and ion regulatory proteins we have 
invited Prof. Adrian Goldman to the RC. In collaboration with his group, several important protein 
structures have been resolved: GDNF/GFRa1 complex, novel neurotrophic factors CDNF and MANF. To 
strengthen the biophysical part of the projects and methodology development we have invited Prof. Juha 
Voipio to the RC. The groups of the CoE have many joint publications together and also with Prof. Goldman 
and Prof. Voipio. The knowhow and expertise of the groups complement each other, both in the basic 
neurobiological research and translational studies. 
 
 
Main scientific field of the RC’s research: biological, agricultural and veterinary sciences 
RC's scientific subfield 1: Neurosciences 
RC's scientific subfield 2: Biology 
RC's scientific subfield 3: Biochemistry and Molecular Biology 
RC's scientific subfield 4: Developmental Biology 
Other, if not in the list:  
 
 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
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Participation category: 4. Research of the participating community represents an innovative opening 
Justification for the selected participation category (MAX. 2200 characters with spaces):  One of the 
strengths of this RC is our activity in applied and translational research. During the last years we have 
actively patented our research findings, signed license and sponsored research agreements with domestic 
and international pharmaceutical and biochemical companies. Our patent portfolio contains more than 
dozen of patents and patent applications. Research agreements with CNS Therapeutics Inc., GSK Ltd., BTD 
Ltd., R&D Systems and several other companies have been sealed. Notably, to promote neuroscience 
applications, the company HermoPharma was established by Prof. Saarma together with H. Rauvala and E. 
Castrén in 2008, with the aim to develop drugs based on the scientific innovations made by the groups of 
the CoE. The main direction of this RC has been to obtain such basic neurobiological results that can be 
applied in the clinics. In preclinical and translational studies, two main results have been obtained that both 
can be stressed as a breakthrough in the treatment of neurological conditions. First, Dr. K. Kaila’s group has 
demonstrated that CO2/pH changes are critically involved in a wide spectrum of neuronal dysfunctions and, 
based on this information, manipulation of brain pH can be used as an effective therapeutic approach to 
treat e.g. birth asphyxic seizures and adult epilepsies. Second, the group of Dr. M. Saarma has discovered 
CDNF, representing a novel family of neurotrophic factors with completely new mode of action and 
currently the best therapeutic potential for the treatment of Parkinson’s disease, but potentially also other 
neurological conditions. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): This RC 
is based on the Finnish Centre of Excellence in Molecular and Integrative Neuroscience Research “Trophic 
factors in neuronal development, plasticity and disease”. It combines internationally recognized 
neuroscience and structural biology groups, all working at the Viikki Biocenter, University of Helsinki. The 
major focus is on the structure and function of neuronal growth factors and ion regulatory proteins in brain 
development, neuronal signaling and basic mechanisms of disease. In basic neuroscience, the research has 
been focusing on the trophic factors and their receptors: their molecular structure and interactions 
function in the development of several organs, and in the pathways of neuronal apoptosis. Another main 
direction has been the role of ion regulatory proteins in the shaping and maintenance of neuronal 
networks, including the dendritic structures. In the preclinical and translational studies, Dr. K. Kaila’s group 
has demonstrated that CO2/pH changes are critically involved in a wide spectrum neuronal dysfunctions 
and, based on this information, manipulation of brain pH can be used as an effective therapeutic approach 
to treat e.g. birth asphyxic seizures and adult epilepsies. Also, the group of Dr. M. Saarma has discovered 
CDNF, representing a novel family of neurotrophic factors with completely new mode of action and great 
therapeutic potential for the treatment of Parkinson’s disease and stroke. The RC is very active in doctoral 
training by supervising PhD students and having leading roles in the national and local doctoral programs. 
Prof. Kai Kaila is the director of the Finnish Graduate School of Neuroscience (FGSN) and Prof. Saarma is a 
board member of the Helsinki Graduate Program in Biotechnology and Molecular Biology (GPBM). 
4 RC'S PARTICIPATION CATEGORY 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
 
 
3 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): Our RC has importance in three major directions: (i) teaching, (ii) scientific 
research, (iii) application of the results and translational research. (i) Kai Kaila is the director of the Finnish 
Graduate School for Neuroscience.  All participant group leaders supervise the undergraduate and graduate 
students and participate in the regular undergraduate and graduate lecturing. E.g. in years 2005-2010 the 
RC successfully supervised 22 PhD dissertations. (ii) The members of the RC have been very successful in 
publishing high-impact papers in the visible international scientific journals (Nature, Nature Medicine, 
Neuron, Journal of Cell Biology, Journal of Neuroscience etc.), giving prestige to the University of Helsinki 
and the Viikki Biocenter. Importantly, the team has been successful in achieving funding from international 
sources, such as H. Lundbeck Foundation, M. J. Fox Foundation for Parkinson’s Research, EU EraNet 
Neuron, EU FP7 EPICURE, and foreign pharmaceutical companies. This in turn creates new jobs to the 
young researchers trained at the University of Helsinki, further increasing its prestige. Several members of 
the team have received domestic and international recognition. E.g. Prof. Kaila obtained the highly 
competitive Sigrid Jusélius “maxi grant” in 2009 and Prof. Saarma received the Nordic Science Price in 2008. 
(iii) Our RC has been successful in translational research. Dr. K. Kaila’s group has demonstrated that CO2/pH 
changes are critically involved in a wide spectrum of neuronal dysfunctions and, based on this information, 
manipulation of brain pH can be used as an effective therapeutic approach to treat e.g. birth asphyxic 
seizures and adult epilepsies. Also, the group of Dr. M. Saarma has discovered CDNF, representing a novel 
family of neurotrophic factors with completely new mode of action and great therapeutic potential for the 
treatment of Parkinson’s disease and stroke. 
Keywords: Neurotrophic factors, neurological diseases, Parkinson’s disease, epilepsy, ion regulatory 
proteins, GABA, KCC2, protein structure, apoptosis, dendritic spines 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): According to the quality of the published 
papers, obtained domestic and international external funding, domestic and international recognition in 
terms of rewards and prices, and the quality and number of trained PhD students, our RC is at the top of 
Finnish bioscience. Probably better than self-assessment is to refer to the regular scientific evaluation of 
our CoE. In the last midterm evaluation report in May 2010 the Scientific Advisory Board of our CoE 
summarized: “The group leaders forming this CoE are considered leaders in their respective fields, they 
have a high international visibility, and have attracted highly respected international scientists to Finland. 
Furthermore, the high-level publications coming out from this CoE speak for themselves... We consider this 
CoE as a unique opportunity to assemble a group of researchers coming from different areas of expertise to 
work on an important and general subject that promotes interactive research leading to top class results 
with high international visibility. The impact of the science done at this CoE reaches from basic towards 
translational neuroscience demonstrating in a perfect manner that basic science is the basis for applied 
science and the future of a country.” 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): In biological and biomedical science, there are commonly accepted criteria for the 
formal evaluation of scientific research. Among the broadly used criteria are: 1. Publications in top 
6 QUALITY OF RC'S RESEARCH AND DOCTORAL TRAINING 
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international journals; 2. Citations of the papers published during the period of assessment; 3. The number 
and quality of supervised PhD students; 4. Funding from domestic and especially international competitive 
sources; 5. Patents, sealed license and sponsored research agreements; 6. Applications of the results in 
terms of new methods of treatments already in use in clinics, development of new drugs or diagnostic 
methods; 7. Scientific prizes and other national and international recognitions. The formal assessment is 
good but not sufficient. Therefore, site visits of top experts and individual assessments of research groups, 
consortia or Institutions are immensely important. The quality of this type of site visit assessment is 
dependent on the quality and experience of the members of the evaluation board. It is also important to 
stress that all sorts of scientific evaluations are meaningful only if the recommendations of the evaluations 
will be implemented. Otherwise they can be even harmful. We have very clear publication strategy: to 
publish in the best possible international journals. Unfortunately this is not always possible. One of the 
main reasons to publish papers in medium-impact journals is the current policy of some faculties (such as 
the Medical Faculty) for PhD studies. According to their current rules, 3-4 papers in the international 
journals are required for the PhD Thesis in the Medical Faculty. In rare occasions have only two very good 
papers been sufficient. In the US and UK universities that are among the top 20 leading universities of the 
world, PhD thesis can be defended with a single high-quality journal. This is a policy that has recently 
received strong support from the Faculty of Biosciences. 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: Molecular and Integrative Neuroscience Research (NeuroIonTroph)
RC-LEADER M. Saarma
CATEGORY 4
Last name First name
PI-status 
(TUHAT, 
29.11.2010)
Title of research and 
teaching personnel Affiliation 
1 Amberg Carolina Doctoral candidate Institute of Biotechnology
2 Andressoo Jaan-Olle x Postdoctoral Researcher Institute of Biotechnology
3 Arumäe Urmas x Senior Researcher - Academy Research Fellow 2006-2011 Institute of Biotechnology
4 Bespalov Maxim Doctoral candidate - postdoctoral researcher Institute of Biotechnology
5 Eesmaa Ave Doctoral candidate Institute of Biotechnology
6 Goldman Adrian x Professor Institute of Biotechnology
7 Helmy Mohamed Doctoral candidate
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
8 Jaakola Veli-Pekka Doctoral candidate University of Oulu
9 Jakobson Maili Doctoral candidate Institute of Biotechnology
10 Kaila Kai x Professor
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
11 Kallijärvi Jukka Postdoctoral Researcher Institute of Biotechnology
12 Kumar Anmol Doctoral candidate Institute of Biotechnology
13 Lehtiö Lari Doctoral candidate Åbo Akademi
14 Li Hong Doctoral candidate Institute of Biotechnology
15 Lindahl Maria Postdoctoral Researcher Institute of Biotechnology
16 Lindholm Päivi Doctoral candidate - postdoctoral researcher Institute of Biotechnology
17 Llano Olaya Doctoral candidate Institute of Biotechnology
18 Ludwig Anastasia Doctoral candidate - postdoctoral researcher Institute of Biotechnology
19 Lume Maria Doctoral candidate Institute of Biotechnology
20 Lyskowski Andrzej Postdoctoral Researcher University of Graz (current)
21 Magalhaes Ana Cathia Doctoral candidate Institute of Biotechnology
22 Marshall Pepin Doctoral candidate Institute of Biotechnology
23 Mätlik Kert Doctoral candidate Institute of Biotechnology
24 Nevalaita-Lonka Liina Postdoctoral Researcher Institute of Biotechnology
25 Palm Erik Doctoral candidate Institute of Biotechnology
26 Parkash Vimal Doctoral candidate Åbo Akademi
27 Patana Anne-Sisko Doctoral candidate Institute of Biotechnology
28 Puskarjov Martin Doctoral candidate
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
29 Rivera Claudio x Senior Researcher - Academy Research Fellow 2003-2008 Institute of Biotechnology
30 Runeberg-Roos Pia Senior Researcher Institute of Biotechnology
31 Ruusuvuori Eva Doctoral candidate - postdoctoral researcher
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
32 Saarma Mart x Professor -          Academy professor Institute of Biotechnology
33 Sen Saurabh Doctoral candidate University of Alabama (current)
34 Shulga Anastasia Doctoral candidate Institute of Biotechnology
35 Sidorova Yulia Postdoctoral Researcher Institute of Biotechnology
36 Smirnov Sergei Postdoctoral Researcher Institute of Biotechnology
37 Timmusk Tönis Senior Researcher Institute of Biotechnology
38 Tokariev Anton Doctoral candidate
Faculty of Biological and Environmental 
Sciences, Department of Biosciences
39 Tolner Else Postdoctoral Researcher
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
40 Viitanen Tero Doctoral candidate
Faculty of Biological and Environmental 
Sciences, Department of Biosciences
41 Virtanen Heidi Doctoral candidate Institute of Biotechnology
42 Voipio Juha x Professor
Faculty of Biological and Environmental 
Sciences, Department of Biosciences
43 Yang Jianmin Doctoral candidate Institute of Biotechnology
44 Yu Liying Doctoral candidate - postdoctoral researcher Institute of Biotechnology
45 Yukin Alexey Doctoral candidate
Faculty of Biological and Environmental 
Sciences, Department of Biosciences and 
Neuroscience Center
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Name of the RC’s responsible person: Saarma, Mart 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Molecular and Integrative Neuroscience Research, 
NeuroionTroph 
The RC’s research represents the following key focus area of UH: 2. Elämän perusrakenne – The basic 
structure of life 
Comments for selecting/not selecting the key focus area: We selected “The basic structure of life” because 
we study the basic biology i.e. the structure and function of the nervous system in normal and pathological 
conditions. Our main goal is to understand how nervous system operates at molecular, cellular and 
organism level. In addition, based on the mechanisms of neuronal processes we also develop drugs for the 
treatment of neurodegenerative and neuropsychiatric diseases. Although one of our major goals is the 
translation of our findings into medical practice, our main work is not a clinical study with patients and 
therefore we did not select “Clinical research”. However, we have a close collaboration with clinicians of 
the Helsinki University Central Hospital. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
Our RC, headed by Prof. M. Saarma, is based on the ”Centre of Excellence in Molecular and Integrative 
Neuroscience Research” (2008-2013) of the Academy of Finland. The present RC includes the CoE teams 
of Saarma, Kaila, Rivera and Arumäe; the other three CoE groups participate in the Neuroscience Center 
evaluation. We have strengthened our RC by two additional groups: the Goldman group, expert in 
structural biology, and the Voipio group focusing on electrophysiology, optical imaging and translational 
research. The members of the RC have a long track-record of successful collaborations.  
 
Neurotrophic factors (NTFs) and ion regulatory proteins (IRPs) are key molecules in neuronal 
development and plasticity. Neuronal activity interacts with the transcription and functions of NTFs and 
IRPs under normal and pathohysiological conditions. Our RC has high-level expertise to address the 
structure, interactions, biology and therapeutic potentials of these biomolecules.  
 
We discovered the novel neurotrophic factor CDNF, potentially the most powerful protein for treating 
Parkinson’s disease (Lindholm et al Nature 2007). CDNF and the related MANF (Palgi et al PNAS 2009; 
Voutilainen et al J Neurosci 2010) form a new highly conserved neurotrophic factor family. CDNF and 
MANF protect and repair dopaminergic neurons in animal models of Parkinson’s disease and stroke. In 
addition, they diffuse better than other NTFs within the brain parenchyma. We have solved the crystal 
structure of CDNF and MANF (Parkash et al Protein Eng 2009). They are comprised of two domains, 
suggesting two distinct functions. CDNF and MANF bind to oxidized phospholipids - a completely new 
property for NTFs, but one predicted by the structure. We have solved the solution structure of MANF 
and its C-terminal domain by NMR (Hellman et al., J Biol Chem 2011). The C-terminal domain is 
structurally homologous to SAP domain proteins, particularly to Ku70 that binds to and blocks the 
apoptotic protein Bax. Notably, CDNF, MANF, and their C-terminal domains can rescue neurons from 
BACKGROUND INFORMATION 
1 FOCUS AND QUALITY OF RC'S RESEARCH (MAX. 8800 CHARACTERS WITH SPACES) 
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apoptotic death induced by Bax. Furthermore, these trophic factors can affect synaptic transmission, 
probably by elevating intracellular Ca2+. 
 
Another main research line deals with the GDNF family of NTFs and their receptors. We have shown that 
syndecan-3 is a novel receptor for GDNF (Bespalov et al., J Cell Biol 2011) and that GDNF-dependent 
dopaminergic neurons die by a novel apoptotic mechanism (Yu et al, J Neurosci 2008). Analysis of GFRa1 
conditional KO and GDNF hypermorphic mice generated in the RC has revealed that GDNF is a critically 
important regulator of adult midbrain dopaminergic neurons. Our current data demonstrate a 
surprisingly broad developmental role for GDNF. It is also responsible for the development of the whole 
urogenital tract. Work on novel splice isoforms of GDNF in neurons has shown that one of them is 
secreted constitutively whereas the other is released in an activity-dependent manner (Lonka-Nevalaita 
et al, J Neurosci 2010). We have solved the structure of the GDNF:GFRa1 complex and identified critical 
amino acids involved in this interaction (Parkash et al., J Biol Chem, 2008). This provides a basis for the 
development of small-molecule GDNF mimetics as lead drugs for the treatment of Parkinson’s disease.  
Our further work on the GDNF-GFRa1 complex identified mechanisms that couple the spacing of the 
GFRas to the kinds of activation that RET undergoes. We have also examined the structure of various 
LRR proteins, including AMIGO. AMIGO-1 directly supports growth of neuronal processes and 
fasciculation of neurites, and our novel structure explains how this may occur. 
 
Another major focus of the RC is on IRPs. Ongoing work on the large intracellular KCC2 C-terminal 
domain has shown that it is natively-unfolded. Two isoforms of the K-Cl cotransporter KCC2 (a,b) are 
transcriptionally regulated during development, and we have shown that upregulation of KCC2b is 
responsible for the maturation of GABAergic signals (Uvarov et al J. Neurosci 2006.; Blaesse et al., 
Neuron 2009). In addition to its role as a Cl  extruder, KCC2 also controls the maturation of the 
glutamatergic transmission by regulating dendritic spine formation via the actin cytoskeleton (Li et al, 
Neuron 2007).  The structural role of KCC2 is likely to be important for the overall development of 
central neurons (Horn et al. EJN 2010). Changes in the efficacy of GABAA transmission are involved in 
epilepsy. In chronically epileptic human hippocampal tissue, a subpopulation of subicular neurons does 
not express KCC2, which leads to the generation of interictal epileptiform activity (Huberfeld et al, J 
Neurosci 2007). KCC2 is upregulated following neonatal seizures, which is opposite to seizure effects in 
the mature brain (Khirug et al, J Neurosci 2010), pointing to age- and trauma -dependent differences in 
the effects of NTFs and IRPs. We have earlier found that BDNF is a critical regulator of KCC2 (Rivera et al 
Nature 1999; J Cell Biol 2002; J Neuroscience 2004). We are currently investigating the mechanisms of 
KCC2 regulation by GDNF and the related growth factor, neurturin. The downregulation of KCC2 in post-
traumatic adult neurons leads to intracellular Cl- accumulation by the Na-K-2Cl cotransporter NKCC1, 
resulting in GABA-induced Ca2+ transients (Shulga et al J Neurosci 2008). This permits neuronal survival 
in a BDNF-dependent manner after injury, while the recovery of KCC2 expression is paralleled by loss of 
this dependency on BDNF. Finally, work based on laser flash uncaging of GABA has demonstrated the 
existence of large intraneuronal Cl- gradients which are maintained by spatially distinct expression 
patterns of KCC2, NKCC1 and other Cl- transporters (Khirug et al J Neurosci 2008). These results imply 
that EGABA is not uniform, and that distinct interneuronal populations trigger qualitatively distinct 
responses in various domains of a target neuron.   
 
The neuronal carbonic anhydrase isoform 7 (CA7) has turned out to be a key molecule in seizure 
generation and a promising anticonvulsant drug target (Ruusuvuori et al. 2004, JNS; Viitanen et al, J 
Physiol 2010). Using a novel CA7 KO, as well as CA2 KO and double CA7/CA2 KO mice, we examined the 
roles of CA isoforms in neuronal pH regulation and in the development of excitatory bicarbonate-
dependent GABA responses in the hippocampus. Strikingly, it is not possible to evoke experimental 
febrile seizures (FS) in the CA7 KO mice. The lack of FS is caused by a change in neuronal pH sensitivity, 
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not by an absence of hyperthermia-induced hyperventilation (cf. Schuchman et al Nature Med 2006). A 
related clinically important observation is that 5% CO2 is a potent anticonvulsant in animal models and 
human epilepsy patients (Tolner et al, Epilepsia  2011). In a novel rodent model of birth asphyxia, two-
photon pH imaging in vivo as well as extracellular pH recordings have shown that birth asphyxia leads to 
a rise in both intra- and extracellular pH in the brain (Helmy et al, Ann Neurol  2011). The experimental 
birth-asphyxia seizures can be suppressed by preventing the fast rise in brain pH during recovery. A 
retrospective clinical study is in progress. 
 
We actively patent our innovations and apply them in practice. We have licensed several technologies to 
biotechnological and pharmaceutical companies (CNS Therapeutics, Inc., R&D Systems Ltd., BTD Ltd., 
Licentia Ltd.). In 2008 we established HermoPharma Ltd., which is developing new CDNF-based drugs for 
the treatment of Parkinson’s disease. Retrospective clinical studies on the effects of CO2/pH on birth 
asphyxic seizures and febrile seizures are on 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
Improving the quality of the RC involves extending our work from structures of individual molecules 
through in vivo imaging and new technologies for transgenic mice. We thus extend collaboration on 
structure with Goldman and the NMR group and collaborate with the faculty of Pharmacy (Tuominen, 
Männistö) on animal models of Parkinson’s disease. Recruitment of post-docs has allowed us to launch 
new technologies for developing conditional knock-out and knock-in mice. Now we plan to develop 
knockout rats. We have launched in vivo approaches that will be developed further. The research on 
IRPs will be extended to the mechanisms of chronic pain in collaboration with Price (Univ. Texas). We 
will enhance collaboration with Bonhoeffer (Max Planck Inst. Neurobiol., Munich) on new ways to 
visualize synaptogenesis using novel two-photon and image analysis approaches combined with 
optogenetics, and with Carlstedt and Risling (Karolinska Inst.) on clinical applications of the role of IRPs 
on BDNF dependency of damaged neurons. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
The members of the RC are closely connected to doctoral programs that are operating in the University 
of Helsinki (Faculty of Biological and Environmental Sciences and Faculty of Medicine). The programs are 
funded by the Ministry of Education and the Academy of Finland. All six RC group leaders belong to the 
Management Board of the Finnish Graduate School of Neuroscience (FGSN; chairman and founder, Kai 
Kaila) and Mart Saarma also to the Scientific Advisory Board of the Helsinki Graduate Program in 
Biotechnology and Molecular Biology (GPBM) and Adrian Goldman to the board of The National 
Doctoral Programme in Informational and Structural Biology (ISB). Nearly all PhD students working in 
the RC are registered to one of the local doctoral programs. The RC follows the guidelines for good 
practices in doctoral training set by the doctoral programs and the faculties. 
 
Doctoral candidates are recruited to doctoral programs by announcing open positions at the University’s 
web site and through relevant national and international email lists. After the call for applications closes, 
the most successful candidates are invited for an interview. 
 
2 PRACTISES AND QUALITY OF DOCTORAL TRAINING (MAX. 8800 CHARACTERS WITH SPACES) 
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An ideal environment for PhD training is created by the interdisciplinary nature and the scientifically 
outstanding senior and postdoctoral researchers of the RC, the Biocentrum Helsinki organization and 
the local collaborators and excellent core facilities at the Institute of Biotechnology, Neuroscience 
Center, Department of Biosciences and Biomedicum.  
 
Each RC group leader is responsible for the day-to-day supervision of the doctoral students and 
postdoctoral researchers in their group. In addition, other senior researchers and postdocs in the RC 
participate in supervising doctoral students in their experimental work. In the beginning of their PhD 
training, a thesis advisory group with two senior researchers (outside of the research group and 
collaborations) is set up for each doctoral student.  The advisory group monitors the progress of the PhD 
work bi-annually until the thesis is ready for dissertation. 
 
In addition to systematic doctoral training, the members of the RC have been active in setting up basic 
master’s level training in neuroscience and biotechnology. The RC group leaders have had a crucial role 
in launching the International Master’s Program in Biotechnology (HEBIOT-program, where Saarma is a 
member of the steering committee) and the International Master’s Program in Neuroscience (MNEURO, 
where Kaila and Voipio are members of the steering committee) within the University of Helsinki. These 
master’s programs have been running since 2006. In addition, Juha Voipio has acted as the vice-dean for 
educational affairs of the Faculty of Biosciences (2007-2009). 
 
All young and advanced researchers meet at a monthly CoE seminar, where PhD students and postdocs 
present their results and progress, which are then discussed. In addition, the CoE has organized a yearly 
two-day meeting where key scientific and technological issues have been discussed. Members actively 
participate in the weekly Neuroscience Seminar Series, which is the major platform for visits by 
internationally renowned scientists. In addition, the RC members have organized several international 
scientific symposia (eg. Cellular Mechanisms of Cortical Functions, 2010; Neurotrophic Factors in Health 
and Disease, 2010; Early development of brain functions: Basic, clinical and translational studies, 2009; 
Brain Development and Plasticity in Health and Disease, 2009; Brain & Pain, 2008; Developing Brain - 
Emerging Mind; 2007; Cortex Inaugural Symposium, 2006) that have been important training events for 
PhD students and senior researchers.  
 
The RC’s research environment is highly international (50% of the RC members are from abroad) and 
inspiring for young researchers. The wide national and international networks of the doctoral programs 
(eg. EU Marie Curie and Tempus networks) as well as the extensive collaboration with research groups 
and biotechnology companies worldwide provide the students an excellent foundation for career 
perspectives both in academia and private sector. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
The close collaboration of the RC groups provides an excellent research and doctoral training 
environment where expertise and facilities are shared. In addition, the national and international 
collaborations in academia and industry expand the interdisciplinary know-how and network even more, 
increasing the career prospective of doctoral students. The active participation of the RC group leaders 
in the doctoral programs strengthens the practices and quality of doctoral training within the RC. 
 
In 2010, a new initiative for Doctoral Program in Brain & Mind (DPBM) was launched by Kai Kaila and 
professors of the Aalto University. The emphasis of the DPBM is to merge the multidisciplinary doctoral 
training of neurosciences and to harmonize the PhD thesis requirements in the University of Helsinki 
and the Aalto University. This program will start in 2012 and it will have a major effect on the practices 
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and quality of doctoral training by building a firm structure of high-level research environments and 
postgraduate education at the main faculties of the biggest universities in Finland. 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
Structural-functional knowledge about novel NTFs and IRPs is actively used in designing new animal 
models and treatment strategies for neurodegenerative diseases such as Parkinson’s and Alzheimer’s 
disease, addiction and epilepsy. The group of Prof. Saarma discovered CDNF, a novel family of 
neurotrophic factors with a completely new mode of action and great therapeutic potential for the 
treatment of Parkinson’s disease and stroke. Key findings on CDNF and related factor MANF are 
patented. Prof. Saarma together with colleagues founded the company HermoPharma, which is 
currently developing CDNF-based drugs for the treatment of Parkinson’s disease. In collaboration with 
CNS Therapeutics, Prof. Saarma and his colleagues have developed novel variants of NTF neurturin with 
improved pharmacokinetic properties. In collaboration with the BTD Ltd. researchers of RC have 
developed small molecules that mimic the action of GDNF on its receptors and are currently being 
tested in the animal models of Parkinson’s disease. Dr. Kai Kaila’s group has carried out translational 
studies on birth-asphyxia and febrile seizures, as well as on adult temporal-lobe epilepsy patients. The 
results suggest that manipulation of brain pH by 5% CO2 has much potential in the treatment of 
seizures. This work was cited as a Highlight in Nature Reviews Neurology (2010). 
 
Members of the RC have numerous patents (in years 2005-2010 five patent families and twelve patent 
applications) and licensing agreements with international and domestic pharmaceutical and 
biotechnological companies (CNS Therapeutics, R&D Systems, Licentia Ltd., BTD Ltd.). The members of 
RC have been and will be active in commercializing the results of the research. M. Saarma is the co-
founder of Mobidiag and HermoPharma Ltd. Helsinki, Finland. To promote the development of CDNF-
based drugs for Parkinson’s disease, M. Saarma received in 2010 a 0.51 M USD grant from Michael J. Fox 
Foundation for Parkinson’s Research. K. Kaila currently received the large grant from S. Jusélius 
Foundation to advance his translational studies on epilepsy. In 2008, M. Saarma received the Nordic 
Science Prize and in 2010 K. Kaila received the 75 Year Anniversary Prize of the Ella and Georg Ehrnrooth 
Foundation. 
 
All groups of the RC are members of the Neurodegenerative Initiative, started by Dr. Saarma. It is a joint 
activity between the University of Helsinki, the city of Helsinki, Sitra and the University of Eastern 
Finland. It combines the 25 best research groups working in the area of neuroscience to design and 
develop completely novel strategies in the patenting, commercialization of neuroscience innovation and 
in collaboration with biotechnology and pharmaceutical companies.  
 
The members of the RC actively promote the visibility of neurobiology by public lectures at the 
University, in the TV and radio, as well as in specific events directed to school teachers and psychiatrists. 
A number of lectures on basic neurobiology and translational research have been given at the University 
Central Hospital and other clinics. In addition, the Finnish Graduate School of Neuroscience has been 
effective in promoting public awareness of neuroscience. 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
The RC will further strengthen its translational research, with bidirectional communication between 
scientists and clinicians. We conduct translational studies on birth-asphyxia and febrile seizures, as well 
as on temporal-lobe epilepsy. In case of novel drugs, a commercial partner is absolutely required. 
3 SOCIETAL IMPACT OF RESEARCH AND DOCTORAL TRAINING (MAX. 4400 CHARACTERS WITH SPACES) 
 6 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 2 MATERIAL  
 
 
Together with HermoPharma and Helsinki University Central Hospital we are preparing phase I clinical 
trials for CDNF. In the frames of Neurodegenerative Initiative we have signed Letters of Intent with GSK 
Ltd. and Eisai.  
 
The doctoral students are encouraged to participate in an intensive training course on biotechnology 
business skills offered by the doctoral programs that gives the students an extensive overview of the 
business environment in biosciences and the prerequisites for productive business operations. In 
addition, they have a possibility to get acquainted with business representatives and their organizations. 
The RC researchers participate in organizing the Brain Awareness Week events every year in March. 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
In the neurotrophic factor research field, we are collaborating with Barry Hoffer (NIDA, NIH) in assessing 
the therapeutic potential of CDNF and MANF in animal models of stroke, with Olle Lindvall and Anders 
Björklund (University of Lund, Wallenberg Neuroscience Center), we are using novel animal models of 
epilepsy and AAV-Cre-based conditional deletion of GDNF. Head of the Interdisciplinary Neuroscience 
Center at the University of Heidelberg, Prof. Klaus Unsicker and the professor of neuroanotomy at the 
University of Göttingen, Kerstin Krieglstein, spent a sabbatical year in 2006 in Prof. Saarma’s laboratory. 
 
In the field of IRPs, the RC’s main collaborators include Dr. Theodore Price (University of Texas), with 
whom we work on the rodent models of chronic pain. Novel transgenic mice have been provided by Dr. 
Christian Hübner (University of Jena). We also investigate the role of the cortical subplate as well as the 
consequences of specific subplate damage in collaboration with Dr. Patrick Kanold (University of 
Maryland). We collaborate with Dr. Corette Wierenga at MPI of Neurobiology on the mechanism of 
synaptogenesis and with Prof. Sami Fransila (Aalto University) to develop novel strategies to implement 
microfuidic systems to the study of synaptogenesis. In collaboration with Prof. Thomas Carlstedt 
(UCL/Karolinska Institute) and Prof. Mårten Risling (Karolinska Institute) we are exploring the possible 
clinical applications of the recently found role of IRPs on BDNF dependency of damaged neurons. Our 
collaborative network on translational studies includes the teams of Dr. Sampsa Vanhatalo at the 
Helsinki University Central Hospital, Dr. Sebastian Schuchmann (Charite, Berlin),  Drs. Mats Blennow and 
Kajsa Bohlin (Karolinska Children’s Hospital); and several members of the FP7-funded project NEMO.  
 
In structural biology, collaborators include Prof. Joel Sussman (Weizmann Inst.), Prof. Andrei Lupas (Max 
Planck Inst. Tübingen) and Prof. Richard Farndale (University of Cambridge). In addition, we collaborate 
with many groups in Finland. 
 
All the above international collaborations involve bidirectional laboratory visits by both junior and senior 
scientists. 
 
The international research and doctoral training collaborations of the RC members are excellent. Kai 
Kaila has been a member of an international research and doctoral training network (partners: Berlin 
Charité/Dirnagl, Bochum/Manahan-Vaughan, Univ. College London/Edwards, Univ. Oslo/Ottersen, 
Prague/Sykova, Stockholm Karolinska/Grillner and Zurich/Schwab): Cooperation in Research and 
Training for European Excellence in the Neurosciences (CORTEX) that was funded by the Marie Curie 
Actions during 2006-2009.  
4 INTERNATIONAL AND NATIONAL (INCL. INTERSECTORAL) RESEARCH COLLABORATION AND RESEARCHER 
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Since the beginning of 2010, Kai Kaila has been the director and grant holder of an EACEA Tempus IV –
funded European and Russian educational cooperation project: Postgraduate Training Network in 
Biotechnology of Neurosciences, BioN (partners: Universities of St. Petersburg, Moscow, Nizhny 
Novgorod and Rostov-on-Don, and the Brain Research Unit of the Medical Research Council at 
Cambridge, École Normale Supérieure in Paris, and the Italian Institute of Technology in Genova). 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
The international collaborations of RC are increasing because our successful translational research and 
unique animal models required in academia and industry. Collaboration on neurotrophic factors and 
IPRs has been initiated with Dr. Y. Shaham (NIDA NIH) and Dr. D. Ron (UCSF) on the models of addiction 
and alcohol abuse, with Prof. H. Tanila (Kuopio) on animal models of Alzheimer’s disease, Karolinska 
Institute, Lund University and Columbia University on the use of conditional knockout mice. Several 
international pharmaceutical companies have contacted us with the aim to license CDNF and GDNF 
technologies.  
 
The Tempus researcher training collaboration project will continue until 2013. The project 
advancements have been recognized by European and Russian institutes that have expressed their 
wishes to join the collaboration.  
 
In Finland, a new initiative, Doctoral Program in Brain & Mind, has been launched in 2010 to merge the 
multidisciplinary doctoral training in the neurosciences of the University of Helsinki and the Aalto 
University. This program will start in 2012 (chair K. Kail 
 
 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
The members of the RC have set up and are maintaining several core facilities providing modern 
sophisticated research techniques in neurobiology and being also available for other researchers: X-Ray 
Crystallography Unit (A. Goldman): structure determination and interaction studies of biological 
macromolecules, Biocenter Finland automated protein crystallization service. Neuronal imaging and 
electrophysiology (K. Kaila): two-photon microscopy, in vivo and in vitro electrophysiology, pH and 
amperometric electrodes for measuring neonate brain pH and oxygen levels in vivo, in utero 
electroporation techniques for expressing IPRs and constructs/mutations thereof. Neuronal 
microinjections: culture and microinjection of primary neurons (U. Arumäe). 
 
The core facilities of the Institute of Biotechnology are also available: Light microscopy unit (two 
confocal microscopes, a TILL imaging system, a Cell-IQ continuous cell culturing platform and two image 
analysis workstations), electron microscopy unit (transmission and scanning EM, cryo-EM, electron 
tomography), protein chemistry unit (analytical techniques for protein and peptide research), DNA 
sequencing and microarray unit, bioinformatics and biocomputing services. In addition, rat 
pharmacological models for neurodegenerative diseases, combining stereotaxic intrabrain injections of 
compounds with histological and behavioral analyses, are available via collaboration with the Faculty of 
Pharmacy, University of Helsinki. Core facilities of the Neuroscience Center are also available for all the 
RC members, including transgenic mouse core facility: production and maintenance of transgenic, 
knockout and knock-in mice; analysis of transgenic mouse phenotype (behaviour-electrophysiology-
5 OPERATIONAL CONDITIONS (MAX. 4400 CHARACTERS WITH SPACES) 
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histology), in vivo two-photon microscopy and intrinsic optical signal recordings. The University of 
Helsinki is establishing a new larger animal facility, Rodentia, with a transgenic mouse facility in the 
Viikki Biocenter. This will allows us to expand the transgenic and behavioural work and definitely 
broadens our possibilities for in vivo studies in general. The Institute of Biotechnology has recently set 
up a completely novel technology – electron tomography that allows automated electron tomography in 
cells . We have recently participated in the establishment of a new imaging technique – SPECT-CD in the 
Viikki campus. This technology using short-living isotope-labeled compounds is extremely useful for our 
in vivo studies on animal models. Dr. Mikko Airavaara was trained as a post-doc at NIDA NIH and he will 
return in summer 2011 and establish novel animal models of addiction and stroke.  
 
According to recent directives by the University of Helsinki and the Academy of Finland, researchers 
must participate in teaching. The RC has already for several years been active in developing novel 
courses in neurobiology, and its members have launched multidisciplinary lecture series as well as 
courses designed for both Master’s and MD/PhD students. 
 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
Our main strength is in the broad competence: we have expertise from structural biology up to 
organism level and close collaboration with industry and clinics. Second, our laboratories are well 
equipped and the Institute of Biotechnology and the Neuroscience Center offer high-level core facility 
services. Third, our collaboration is close, as is reflected by our many joint high-level publications. 
Finally, we have enthusiastic junior scientists and a very good working atmosphere at our RC.  
 
The main challenge is the shortage of basic funding in Finland. Finland spends 3.6% of the GDP on R&D - 
but just 0.5% on basic research. Therefore we have difficulties recruiting new people, maintaining core 
facilities or starting new research directions. Another challenge is to attract most talented young people 
to science, as over the years the quality and motivation of the graduate students has gradually 
decreased. Finally, too few graduate students and especially post-docs come to Finland from the 
Western world. 
 
 
 
 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
The RC consists of six research groups working at the University of Helsinki Biocenter at Viikki campus. 
The groups of principal investigators Saarma, Arumäe, Goldman and Rivera are in the Institute of 
Biotechnology and the groups of Kaila and Voipio are in the Department of Biological and Environmental 
Sciences. The RC leader Mart Saarma acts as the chairman and Kai Kaila as a vice chairman in the 
Assembly formed by the group leaders. All strategic decisions, such as funding, recruitment, purchase of 
new equipment etc. are discussed at the meeting of the Assembly, which meets 2-4 times per year. The 
RC leader is responsible for the implementation of the financing policy.  
 
Scientific administration is mainly taken care by the RC leader together with the vice-leader and co-
ordinators of the research topics of the RC. They frequently discuss scientific issues and collaboration, 
need for novel facilities, need for an Assembly meeting, and other timely issues of the RC. Organization 
of scientific symposia in the context of researcher training and of neuroscience courses for graduate and 
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postgraduate students is one of the major issues requiring frequent communication of the RC leader 
with the group leaders. In the RC policy, the responsible department for administrating the RC is the 
Institute of Biotechnology. The administration of the Institute of Biotechnology (explained in 
www.helsinki.fi/bi/) is available for administrative issues, including the budget, of the proposed RC. 
Financial secretary Katriina Vaittinen helps the groups in financial administration. RC organizes monthly 
RC seminars where each time one group presents their newest results. Currently the seminars are 
coordinated by Dr. U. Arumäe. In addition, the RC organizes a retreat once a year to discuss the progress 
in science, doctoral training and applications of the basic research. RC has a Scientific Advisory Board 
(SAB) consisting of two members: Prof. Kerstin Krieglstein (University of Freiburg) and Prof. Michael 
Sendtner (University of Würtzburg). The SAB makes a site visit every second year and writes a report on 
the scientific achievements, management and social impact of the RC. The report is partially based on 
the Progress Report of the RC that is compiled annually. In addition to the written material, a meeting of 
the SAB with the RC staff will be held with 2 year intervals. These meetings include selected lectures by 
the group leaders followed by a poster exhibition allowing the young researchers to present their 
results. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
Strengths: 1. Experience. Prof. Saarma has a long experience of science administration, having been 
director of the Institute of Biotechnology for 18 years and a founder and 2-year director of the Biocenter 
of Finland. Currently he is the leader of the CoE of the Academy of Finland and the member of the 
EMBO Council and ERC Scientific council. Prof. Kai Kaila has been chairman of the Department of 
Biosciences for many years. He is the director of FSGN and a member of the board of International 
Graduate School in Neurosciences. Saarma and Kaila are the members of several international and 
domestic scientific advisory boards. 2. Our RC is administrated by the flexible system of the Institute of 
Biotechnology. 3. The groups of our RC have functioned together over many years, both scientifically 
and administratively. Our major challenge is to get top class woman group leaders. We try to solve this 
problem by recruiting talented female post-docs. Also, the bureaucracy in the University Science 
administration has recently significantly increased. This needs serious analysis and changes. 
 
 
 
 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 4800000 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 710000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 2750000 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
7 EXTERNAL COMPETITIVE FUNDING OF THE RC 
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 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Sigrid Juselius Foundation 
- Michael J. Fox Foundation for Parkinson's Research 
- Jane and Aatos Erkko Foundation 
- Letten Foundation 
- Lundbeck Foundation 
- total amount of funding (in euros) from the above-mentioned foundations: 4150000 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations: Nordic Council of Ministers 
- NordForsk 
- CNS Therapeutics, Inc. USA 
- BTD Ltd., Estonia 
- total amount of funding (in euros) from the above-mentioned funding organizations: 860000 
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: Ministry of Education and Culture 
- CIMO 
- total amount of funding (in euros) from the above-mentioned funding organizations: 960000 
 
 
 
 Description of the RC’s future perspectives in respect to research and doctoral training. 
1. Improvement of the quality of scientific research.  
The combination of different research methods in structural biology/biochemistry, electrophysiology, 
cellular imaging and animal behavior in our RC paves the way to novel and unexpected observations not 
possible by sticking just to a handful of methods. The size of the RC is large enough to produce a critical 
mass of knowledge and experience on the one hand, but small enough to ensure efficient exchange of 
interdisciplinary and creative ideas. Research collaborations with outside groups effectively distribute 
the research experience and methodology developed in the RC.  
 
2. Enhancing translational research, increasing industrial contacts and applications of the research 
results. 
The RC has filed twelve patent families in 2005-2010 and had many research contracts or licensing 
agreements with international and domestic pharmaceutical and biotechnology companies (R&D 
Systems Ltd., BTD Ltd, Licentia Ltd, CNS Therapeutics Inc.). The members of the RC will carry out active 
patenting and commercialization program where key innovations will be patented and licensed to 
domestic and foreign companies. The RC is currently carrying out business negotiations for licensing 
with GSK China, Roche and Eisai).  
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Special attention will be paid to the research projects of the RC with potential important clinical 
applications in the diagnostics and treatment of neurological and neurodegenerative disorders. In 
particular, the development of CDNF as a drug for the treatment of Parkinson’s disease will be together 
with HermoPharma taken to Phase I clinical trials that will start in 2012 at the Helsinki University Central 
Hospital.  
 
In Finland with its population of 5 million, the burden of costs of brain diseases (direct and indirect) 
imposed on the society is estimated at about 4 billion Euros per year. Hence, translational research on 
brain diseases has a tremendous potential in not only enhancing individual human life quality but also 
that of society as a whole. We are launching new initiatives at the level of early human brain 
development, where successful therapeutic interventions produce, by definition, life-long benefits. To 
this end, our RC is developing novel animal models relevant for studying disease mechanisms at the 
neonate and infant stage. These models are being developed in close collaboration with the clinicians. 
Furthermore, parallel studies on brain functions in preterm and full-term babies and neonate rodents 
will provide important information on the unique properties of the normal and diseased immature 
brain. For instance, it has become obvious that the majority of babies who have epileptic seizures 
receive medication that is largely ineffective or even harmful. Addressing these problems will be done 
by concerted research efforts by the RC’s basic scientists and clinicians. 
 
3. Increasing the quality of doctoral training.  
Traditionally, a biomedical PhD thesis in Finnish Universities is based on 3-4 original papers, with one of 
them first-authored by the student. As a result, a doctoral student receives her/his PhD at an age 
around 30 years, which is much higher than for instance in the US and UK. The requirement of 3-4 
publications often leads to a compromise in the quality of science. Therefore, the RC and the FGSN will 
encourage PhD students and their supervisors to aim at theses with 1-2 high-quality publications, which 
is formally accepted (but often not implemented) in the Faculty of Biosciences. Other means to improve 
doctoral training are described in Section 2.        
 
4. Promoting research careers for woman scientists and young researchers.  
We recognize that, despite high levels of qualification and motivation, young scientists, in particular 
women, terminate their academic careers due to unattractive overall conditions. To promote female 
researchers in our field of research we have currently recruited a number of female post-docs and we 
plan to continue in this line. We hope that this policy will bring new talented female group leaders. 
 
5. Launching new technologies and development of core facilities.  
We will focus on further development of in vivo imaging, optogenetic methods and launching novel 
transgenic technologies including the development of gene-deficient rats. 
 
 
 
All group leaders had a meeting where the issues needed for stage 2 of the evaluation were discussed. 
Prof. Saarma and Dr. Arumäe wrote the drafts for the scientific and science application parts and Prof. 
Kaila for the doctoral training part. All group leaders then complemented the texts. Katri Wegelius, the 
coordinator of the Finnish Graduate School of Neuroscience prepared all the materials related to the 
personnel, publications, grants etc. 
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1 Analysis of publications 
 
- Associated person is one of Carolina Louise Amberg ,  Jaan-Olle Andressoo , Urmas Arumäe , 
 Maxim Bespalov ,  Adrian Goldman , Mohamed Mustafa Mahmoud Helmy , 
 Maili Jakobson ,  Kai Kaila ,  Jukka Kallijärvi , Anmol Kumar , 
Lari Tapio Lehtiö, Maria Susanna Lindahl ,  Päivi Katariina Lindholm ,  Olaya Llano 
Sanchez ,  Anastasia Ludwig ,  Maria Lume ,  Andrzej Lyskowski , 
 Pepin Oliver Launcelot Marshall , Kert Mätlik ,  Liina Nevalaita , 
 Vimal Parkash ,  Anne-Sisko Patana , Martin Puskarjov , 
 Claudio Rivera Baeza ,  Pia Runeberg-Roos ,  Eva Ruusuvuori , 
 Mart Saarma ,  Saurabh Sen, Anastasia Shulga ,  Yulia Sidorova , 
 Sergei Smirnov , Else Tolner ,  Heidi Virtanen , Juha Voipio , 
 Jianmin Yang, Liying Yu ,  Alexey Yukin ,  
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 25 23 26 24 18 23 139 
A2 Review in scientific journal 3  2 1 1  7 
A3 Contribution to book/other compilations (refereed) 2 1  2 1 7 13 
A4 Article in conference publication (refereed)  4    1 5 
B1 Unrefereed journal article 1      1 
D1 Article in professional journal    1 1  2 
E1 Popular contribution to book/other compilations  1     1 
H1 Patents  1 1    2 
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2 Listing of publications 
A1 Refereed journal article 
2005 
Alakuijala, A, Palgi, M, Wegelius, K, Schmidt, M, Enz, R, Paulin, L, Saarma, M, Pasternack, M 2005, 'GABA receptor subunit expression 
in the developing rat brain', Developmental Brain Research, vol 154, no. 1, pp. 15-23. 
Andressoo, JO, Hoeijmakers, JHJ, de Waard, H 2005, 'Nucleotide excision repair and its connection with cancer and ageing',  
Advances in Experimental Medicine and Biology, vol 570, pp. 45-81. 
Andressoo, JO, Hoeijmakers, JHJ 2005, 'Transcription-coupled repair and premature ageing', Mutation Research - Fundamental and 
Molecular Mechanisms of Mutagenesis, vol 577, pp. 179-194. 
Aurikko, JP, Ruotolo, BT, Grossmann, JG, Moncrieffe, MC, Stephens, E, Leppänen, V, Robinson, CV, Saarma, M, Bradshaw, RA, 
Blundell, TL 2005, 'Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin 
receptor, p75[sup NTR]', Journal of Biological Chemistry, vol 280, no. 39, pp. 33453 - 33460. 
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Shulga, A, Thomas-Crusells, J, Sigl, T, Blaesse, A, Mestres, P, Meyer, M, Yan, Q, Kaila, K, Saarma, M, Rivera, C, Giehl, KM 2008, 
'Posttraumatic GABA(A)-mediated [Ca2+](i) increase is essential for the induction of brain-derived neurotrophic factor-dependent 
survival of mature central neurons', Journal of Neuroscience, vol 28, no. 27, pp. 6996-7005. 
Shulga, A, Thomas-Crusells, J, Sigl, T, Blaesse, A, Mestres, P, Meyer, M, Yan, Q, Kaila, K, Saarma, M, Rivera, C, Giehl, KM 2008, 
'Posttraumatic GABA[subA]-mediated [Ca²][subi] increase is essential for the induction of brain-derived neurotrophic factor-dependent 
survival of mature central neurons', Journal of Neuroscience, vol 28, no. 27, pp. 6996-7005. 
Vanhatalo, S, Kaila, K 2008, 'Generation of "positive slow waves" in the preterm EEG: By the brain or by the EEG setup?', Clinical 
Neurophysiology, vol 119, no. 6, pp. 1453-1454. 
Xiong, Y, Patana, A, Miley, MJ, Zielinska, AK, Bratton, SM, Miller, GP, Goldman, A, Finel, M, Redinbo, MR, Radominska-Pandya, A 
2008, 'The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during 
catalysis', Drug Metabolism and Disposition, vol 36, no. 3, pp. 517-522. 
Yu, L, Saarma, M, Arumäe, U 2008, 'Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived 
dopaminergic neurons', Journal of Neuroscience, vol 28, no. 30, pp. 7467-7475. 
Yu, L, Arumäe, U 2008, 'Survival assay of transiently transfected dopaminergic neurons', Journal of Neuroscience Methods, vol 169, 
no. 1, pp. 8-15. 
2009 
Airavaara, M, Shen, H, Kuo, C, Peränen, J, Saarma, M, Hoffer, B, Wang, Y 2009, 'Mesencephalic astrocyte-derived neurotrophic factor 
reduces ischemic brain injury and promotes behavioral recovery in rats', Journal of Comparative Neurology, vol 515, pp. 116-124. 
Andressoo, J, Weeda, G, de Wit, J, Mitchell, JR, Beems, RB, van Steeg, H, van der Horst, GTJ, Hoeijmakers, JH 2009, 'An Xpb Mouse 
Model for Combined Xeroderma Pigmentosum and Cockayne Syndrome Reveals Progeroid Features upon Further Attenuation of DNA 
Repair', Molecular and Cellular Biology, vol 29, no. 5, pp. 1276-1290. 
Coleman, SK, Möykkynen, T, Jouppila, A, Koskelainen, S, Rivera, C, Korpi, ER, Keinänen, K 2009, 'Agonist occupancy is essential for 
forward trafficking of AMPA receptors', Journal of Neuroscience, vol 29, no. 2, pp. 303-312. 
Hartmann, AM, Blaesse, P, Kranz, T, Wenz, M, Schindler, J, Kaila, K, Friauf, E, Nothwang, HG 2009, 'Opposite effect of membrane raft 
perturbation on transport activity of KCC2 and NKCC1', Journal of Neurochemistry, vol 111, no. 2, pp. 321-331. 
Hotulainen, P, Llano, O, Smirnov, S, Tanhuanpää, K, Faix, J, Rivera Baeza, C, Lappalainen, P 2009, 'Defining mechanisms of actin 
polymerization and depolymerization during dendritic spine morphogenesis', Journal of Cell Biology, vol 185, no. 2, pp. 323-339. 
Jia, J, Maccarana, M, Zhang, X, Bespalov, MM, Lindahl, U, Li, J 2009, 'Lack of L-iduronic acid in heparan sulfate affects interaction with 
growth factors and cell signaling', Journal of Biological Chemistry, vol 284, no. 23, pp. 15942-15950. 
Kajander, T, Sachs, JN, Goldman, A, Regan, L 2009, 'Electrostatic interactions of Hsp-organizing protein tetratricopeptide domains with 
Hsp70 and Hsp90: computational analysis and protein engineering', Journal of Biological Chemistry, vol 284, no. 37, pp. 25364-
25374. 
 
 
Neuroiontroph/Saarma 
 
 
7 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC TUHAT COMPILATIONS OF PUBLICATIONS DATA 2005-2010 
 
 
Karlberg, S, Lipsanen-Nyman, M, Lassus, H, Kallijärvi, J, Lehesjoki, A, Butzow, R 2009, 'Gynecological tumors in Mulibrey nanism and 
role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas',  Modern Pathology, vol 22, pp. 570-578. 
Leo, JC, Goldman, A 2009, 'The immunoglobulin-binding Eib proteins from Escherichia coli are receptors for IgG Fc',  Molecular 
Immunology, vol 46, no. 8-9, pp. 1860-1866. 
Palgi, M, Lindström, R, Peränen, J, Piepponen, P, Saarma, M, Heino, TI 2009, 'Evidence that DmMANF is an invertebrate neurotrophic 
factor supporting dopaminergic neurons', Proceedings of the National Academy of Sciences of the United States of America, vol 
106, no. 7, pp. 2429-2434. 
Parkash, V, Goldman, A 2009, 'Comparison of GFL-GFR compexes: further evidence relating GFL blend angle to RET signalling', Acta 
crystallographica. Section F: Structural biology and crystallization communications , vol F65, no. 6, pp. 551-558. 
Parkash, V, Lindholm, P, Peränen, J, Kalkkinen, N, Oksanen, E, Saarma, M, Leppänen, V, Goldman, A 2009, 'The structure of the 
conserved neurotrophic factors MANF and CDNF explains why they are bifunctional', Protein Engineering, Design and Selection, vol 
22, no. 4, pp. 233-241. 
Piltonen, M, Bespalov, MM, Ervasti, D, Matilainen, T, Sidorova, YA, Rauvala, H, Saarma, M, Männistö, PT  2009, 'Heparin-binding 
determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons',  Experimental 
Neurology, vol 219, no. 2, pp. 499-506. 
Schuchmann, S, Vanhatalo, S, Kaila, K 2009, 'Neurobiological and physiological mechanisms of fever-related epileptiform syndromes',  
Brain & Development, vol 31, pp. 378-382. 
Shulga, A, Blaesse, A, Kysenius, K, Huttunen, HJ, Tanhuanpaa, K, Saarma, M, Rivera, C 2009, 'Thyroxin regulates BDNF expression to 
promote survival of injured neurons', Molecular and Cellular Neuroscience, vol 42, no. 4, pp. 408-418. 
Sipila, ST, Huttu, K, Yamada, J, Afzalov, R, Voipio, J, Blaesse, P, Kaila, K 2009, 'Compensatory enhancement of intrinsic spiking upon 
NKCC1 disruption in neonatal hippocampus', Journal of Neuroscience, vol 29, no. 21, pp. 6982-6988. 
Uvarov, P, Ludwig, A, Markkanen, M, Soni, S, Hubner, CA, Rivera, C, Airaksinen, MS 2009, 'Coexpression and Heteromerization of 
Two Neuronal K-Cl Cotransporter Isoforms in Neonatal Brain', Journal of Biological Chemistry, vol 284, no. 20, pp. 13696-13704. 
Voutilainen, M, Bäck, S, Pörsti, E, Toppinen, L, Lindgren, L, Lindholm, P, Peränen, J, Saarma, M, Tuominen, RK  2009, 'Mesencephalic 
astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's Disease',  Journal of Neuroscience, vol 29, no. 30, 
pp. 9651-9659. 
2010 
Asiedu, M, Ossipov, MH, Kaila, K, Price, TJ 2010, 'Acetazolamide and midazolam act synergistically to inhibit neuropathic pain', Pain : 
the journal of the International association for the study of pain, vol 148, no. 2, pp. 302-308. 
Bhattacharjee, A, Lehtinen, MJ, Kajander, T, Goldman, A, Jokiranta, TS 2010, 'Both domain 19 and domain 20 of factor H are involved 
in binding to complement C3b and C3d', Molecular Immunology, vol 47, no. 9, pp. 1686-1691. 
Carta, F, Temperini, C, Innocenti, A, Scozzafava, A, Kaila, K, Supuran, CT  2010, 'Polyamines Inhibit Carbonic Anhydrases by Anchoring 
to the Zinc-Coordinated Water Molecule', Journal of Medicinal Chemistry, vol 53, no. 15, pp. 5511-5522. 
Gyarfas, T, Knuuttila, J, Lindholm, P, Rantamäki, T, Castrén, E 2010, 'Regulation of Brain-Derived Neurotrophic Factor (BDNF) and 
Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo', Cellular and Molecular Neurobiology, 
vol 30, pp. 361-368. 
Hellman, M, Peränen, J, Saarma, M, Permi, P 2010, '1H, 13C and 15N resonance assignments of the human mesencephalic astrocyte-
derived neurotrophic factor.', Biomolecular NMR assignments, vol 4, no. 2, pp. 215-217. 
Horn, Z, Ringstedt, T, Blaesse, P, Kaila, K, Herlenius, E 2010, 'Premature expression of KCC2 in embryonic mice perturbs neural 
development by an ion transport-independent mechanism', European Journal of Neuroscience, vol 31, no. 12, pp. 2142-2155. 
Khirug, S, Ahmad, F, Puskarjov, M, Afzalov, R, Kaila, K, Blaesse, P 2010, 'A Single Seizure Episode Leads to Rapid Functional 
Activation of KCC2 in the Neonatal Rat Hippocampus', Journal of Neuroscience, vol 30, no. 36, pp. 12028-12035. 
Koutsioulis, D, Lyskowski, A, Mäki, S, Guthrie, E, Feller, G, Bouriotis, V, Heikinheimo, P 2010, 'Coordination sphere of the third metal 
site is essential to the activity and metal selectivity of alkaline phosphatases', Protein Science, vol 19, no. 1, pp. 75-84. 
Käenmäki, M, Tammimäki, AE, Myöhänen, TT, Pakarinen, K, Amberg, CL, Karayiorgou, M, Gogos, J, Männistö, P 2010, 'Quantitative 
role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice',  Journal of Neurochemistry, vol 114, no. 6, pp. 
1745-1755. 
Leo, JC, Goldman, A 2010, 'Jacks of all trades?-Probably not: The E. coli Eib proteins bind IgG Fc', Molecular Immunology, vol 47, no. 
9, pp. 1870-1872. 
Leo, JC, Elovaara, H, Bihan, D, Pugh, N, Kilpinen, SK, Raynal, N, Skurnik, M, Farndale, RW, Goldman, A 2010, 'First Analysis of a 
Bacterial Collagen-Binding Protein with Collagen Toolkits: Promiscuous Binding of YadA to Collagens May Explain How YadA Interferes 
with Host Processes', Infection and Immunity, vol 78, no. 7, pp. 3226-3236. 
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Leppänen, V, Prota, AE, Jeltsch, M, Anisimov, A, Kalkkinen, N, Strandin, T, Lankinen, H, Goldman, A, Ballmer-Hofer, K, Alitalo, K 2010, 
'Structural determinants of growth factor binding and specificity by VEGF receptor 2', Proceedings of the National Academy of 
Sciences of the United States of America, vol 107, no. 6, pp. 2425-2430. 
Lindholm, PK, Saarma, M 2010, 'Novel CDNF/MANF Family of Neurotrophic Factors', Developmental Neurobiology, vol 70, no. 5, pp. 
360-371. 
Lonka-Nevalaita, L, Lume, M, Leppänen, SM, Jokitalo, E, Peränen, J, Saarma, M 2010, 'Characterization of the Intracellular 
Localization, Processing, and Secretion of Two Glial Cell Line-Derived Neurotrophic Factor Splice Isoforms', Journal of Neuroscience, 
vol 30, no. 34, pp. 11403-11413. 
Molotkov, D, Yukin, A, Afzalov, R, Khirug, L 2010, 'Gene delivery to postnatal rat brain by non-ventricular plasmid injection and 
electroporation.', Journal of Visualized Experiments, no. 43. 
Oksanen, E, Dauvergne, F, Goldman, A, Budayova-Spano, M 2010, 'Design of a novel Peltier-based cooling device and its use in 
neutron diffraction data collection of perdeuterated yeast pyrophosphatase', Journal of Applied Crystallography, vol 43, no. 5, pp. 
1113-1120. 
Ora, A, Oksanen, E, Kajander, T, Goldman, A, Butcher, SJ  2010, 'Crystallization and preliminary crystallographic analysis of mouse 
peroxiredoxin II with significant pseudosymmetry', Acta crystallographica. Section F: Structural biology and crystallization 
communications , vol 66, pp. 357-360. 
Planken, A, Porokuokka, L, Hänninen, A, Tuominen, R, Andressoo, J 2010, 'Medium-throughput computer aided micro-island method to 
assay embryonic dopaminergic neuron cultures in vitro', Journal of Neuroscience Methods, vol 194, no. 1, pp. 122-131. 
Ruusuvuori, E, Kaila, K, Kirilkin, I, Pandya, N 2010, 'Spontaneous Network Events Driven by Depolarizing GABA Action in Neonatal 
Hippocampal Slices are Not Attributable to Deficient Mitochondrial Energy Metabolism', Journal of Neuroscience, vol 30, no. 46, pp. 
15638-15642. 
Sidorova, Y, Mätlik, K, Paveliev, M, Lindahl, M, Piranen, E, Milbrandt, J, Arumäe, U, Saarma, M, Bespalov, M 2010, 'Persephin signaling 
through GFR alpha 1: The potential for the treatment of Parkinson's disease', Molecular and Cellular Neuroscience, vol 44, no. 3, pp. 
223-232. 
Tolner, E, Hochman, D, Hassinen, P, Otáhal, J, Gaily, E, Haglund, M, Kubová, H, Schuchmann, S, Vanhatalo, S, Kaila, K 2010, '5% 
CO2 is a potent, fast acting inhalation anticonvulsant', Epilepsia, vol 52, no. 1, pp. 104-114. 
Tuominen, H, Salminen, A, Oksanen, E, Jamsen, J, Heikkila, O, Lehtio, L, Magretova, NN, Goldman, A, Baykov, AA, Lahti, R  2010, 
'Crystal Structures of the CBS and DRTGG Domains of the Regulatory Region of Clostridium perfringens Pyrophosphatase Complexed 
with the Inhibitor, AMP, and Activator, Diadenosine Tetraphosphate', Journal of Molecular Biology, vol 398, pp. 400-413. 
Viitanen, T, Ruusuvuori, E, Kaila, K, Voipio, J 2010, 'The K plus -Cl- cotransporter KCC2 promotes GABAergic excitation in the mature 
rat hippocampus', Journal of Physiology, vol 588, no. 9, pp. 1527-1540. 
A2 Review in scientific journal 
2005 
Rivera, C, Voipio, J, Kaila, K 2005, 'Two developmental switches in GABAergic signalling: the K-Cl cotransporter KCC2 and carbonic 
anhydrase CAVII', Journal of Physiology, vol 562, no. 1, pp. 27-36. 
Vanhatalo, S, Voipio, J, Kaila, K 2005, 'Full-band EEG (fbEEG): a new standard for clinical electroencephalography', Clinical EEG and 
neuroscience, vol 36, pp. 311-317. 
Vanhatalo, S, Voipio, J, Kaila, K 2005, 'Full-band EEG (FbEEG): an emerging standard in electroencephalography', Clinical 
Neurophysiology, vol 116, no. 1, pp. 1-8. 
2007 
Bespalov, MM, Saarma, M 2007, 'GDNF family receptor complexes are emerging drug targets', Trends in Pharmacological Sciences, 
vol 28, no. 2, pp. 68-74. 
Runeberg-Roos, P, Saarma, M 2007, 'Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases', Annals of 
Medicine, vol 39, pp. 572-580. 
2008 
Andressoo, J, Saarma, M 2008, 'Signalling mechanisms underlying development and maintenance of dopamine neurons', Current 
Opinion in Neurobiology, vol 18, no. 3, pp. 297-306. 
2009 
Blaesse, P, Airaksinen, MS, Rivera , C, Kaila, K 2009, 'Cation-chloride cotransporters and neuronal function',  Neuron, vol 61, no. 6, pp. 
820-838. 
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A3 Contribution to book/other compilations (refereed) 
2005 
Vanhatalo, S, Voipio, J, Kaila, K 2005, 'Infraslow EEG activity', in E Niedermeyer, F Lopes da Silva (eds), Electroencephalography: 
Basic Principles, Clinical Applications, and Related Fields, 5 edn, Lippincott Williams & Wilkins, Baltimore, pp. 489-493. 
Vanhatalo, S, MIller, J, Holmes, M, Kaila, K, Voipio, J 2005, 'Full-band EEG in locating slow ictal events', Epilepsy Surgery. Principles 
and Controversies., Marcel Dekker. 
2006 
Vanhatalo, S, Voipio, J, Kaila, K, Miller, J, Holmes, M 2006, 'Use of full-band EEG for noninvasive ictal localization', in J Miller, D 
Silbergeld (eds), Epilepsy Surgery, Principles and Controversies, Informa healthcare, New York, pp. 745-751. 
2008 
Paveliev, M, Saarma, M 2008, 'Information processing by NGF-activated signaling networks', in GK McIntire (ed.), Nerve Growth 
Factor. New Research., Nova Science Publishers, New York, pp. 345-358. 
Sipilä, ST, Kaila, K 2008, 'GABAergic Control of CA3-driven network events in the developing hippocampus', in M Darlison (ed.) , 
Inhibitory Regulation of Excitatory Neurotransmission. Springer Verlag 2008., Results and problems in cell differentiation, 44, 
Springer-Verlag, Heidelberg, pp. 99-121. 
2009 
Saarma, M 2009, 'GFL neurotrophic factors: physiology and pharmacology', in ELRS (ed.), Encyclopedia of neuroscience, Elsevier 
Academic Press,, Amsterdam, pp. 711-720. 
2010 
Oksanen, E, Goldman, A 2010, 'X-ray Crystallography', in L Mander, B Liu (eds), Comprehensive Natural Products Chemistry II, vol. 
9, Elsevier, Amsterdam. 
Sipilä, ST, Kaila, K 2010, 'GABAergic transmission and neuronal network events during hippocampal development', in S Pallas (ed.), 
Developmental Plasticity of Inhibitory Circuitry, Springer. 
Sipilä, ST, Blaesse, P, Kaila, K 2010, 'Development of GABAergic signaling: from molecules to emerging networks', in MS Blumberg et 
al, JH Freeman, SR Robinson (eds), Oxford Handbook of Developmental Behavioral Neuroscience, Oxford library of 
neuroscience, Oxford University Press, New York, pp. 108-. 
Vanhatalo, S, Kaila, K 2010, 'Emergence of spontaneous and evoked EEG activity in the human brain', in H Lagercrantz, M Hanson, P 
Evrard, C Rod, LR Ment, DM Peebles (eds), The Newborn Brain: Neuroscience and Clinical Applications, 2 edn, Cambridge 
University Press, United Kingdom, pp. 229-244. 
Vanhatalo, S, Kaila, K 2010, 'Association analyses of 249,796 individuals evoked EEG activity in the human brain', in H Lagercrantz et 
al (ed.), The Newborn Brain. Neuroscience and Clinical Applications (2nd Ed)., Cambridge University Press, pp. 229-244. 
Vanhatalo, S, Voipio, J, Kaila, K 2010, 'Infraslow EEG activity', in E Niedermeyer et al (ed.), Electroencephalography. Basic 
Principles, Clinical Applications, and Related Fields., Williams & Wilkins, Baltimore-Munich, pp. 489-493. 
Voipio, J 2010, 'Recording of bioelectrical signals: theory and practice', in R Splinter (ed.), Handbook of Physics in Medicine and 
Biology, CRC Press, Taylor & Francis Group ,, Boca Raton, pp. 21: 1-10. 
A4 Article in conference publication (refereed) 
2006 
Hoeijimakers, J, Andressoo, J-, Niedernhofer, L, van der Pluijm, I, Diderich, K, Lalai, A, de Waard, H, Garinis, G, Mitchell, J, Beems, RB, 
van Steeg, H, van der Horst, GTJ 2006, DNA damage repair and the connection with cancer and aging,, FEBS Journal 273 WILEY-
BLACKWELL PUBLISHING LTD.. 
Hoeijmakers, JHJ, Garinis, G, van der Pluijm, I, Mitchell, J, Andressoo, J, Diderich, K, Lalai, A, de Waard, H, Beems, D, van Steeg, H, 
Niedernhofer, L, van der Horst, B 2006, Genome instability and accelerated ageing: The relevance for normal ageing and life span 
extension,, Mutagenesis 21 OXFORD UNIVERSITY PRESS. 
Hoeijmakers, JHJ, Niedernhofer, LJ, Andressoo, JO, van Der Pluijm, I, Diderich, K, Lalai, AS, De Waard, H, Garinis, G, Mitchell, JR, 
Beems, RB, van Steeg, H, van Der Horst, GTJ 2006, DNA damage and the connection with aging: mouse models with repair defects 
and accelerated aging,, Paper presented at Biennial Meeting of the Society-for-Free-Radical-Research-International, Davos, 
Switzerland. 15. - 19. August, 2006. Free Radical Research 40 Supplement 1 INFORMA HEALTHCARE. 
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Hoejmakers, J, Garinis, G, van der Plujim, I, Mitchell, J, Andressoo, JO, Diderich, K, Lalai, A, de Waard, H, Beems, RB, van Steeg, H, 
Niedernhofer, L, van der Horst, GTJ 2006, DNA damage repair, cancer, ageing and life span extension,, Frontiers of Hormone 
Research 65 S./KARGER AG. 
2010 
Saarma, M, Lindholm, P, Andressoo, J-, Perlinen, J, Lindahl, M 2010, Novel Neurotrophic Factor CDNF: Biology and Therapeutic 
Potential,, Cell Transplantation 19 3 COGNIZANT COMMUNICATION CORP.. 
B1 Unrefereed journal article 
2005 
Donner, K, Kaila, K, Voipio, J 2005, 'Eläinkokeiden vaikea etiikka', Suomen lääkärilehti , vol 60, no. 51/52, pp. 5304-5305. 
D1 Article in professional journal 
2008 
Shulga, A, Thomas-Crusells, J, Sigl, T, Blaesse, A, Mestres, P, Meyer, M, Yan, Q, Kaila, K, Saarma, M, Rivera Baeza, C, Giehl, K 2008, 
'Vaurioituneet hermosolut saavat kehityksenaikaisia ominaisuuksia',  Duodecim, vol 124, pp. 1766. 
2009 
Shulga, A, Blaesse, A, Kysenius, K, Huttunen, HJ, Tanhuanpää, K, Saarma, M, Rivera Baeza, C 2009, 'Tyroksiini edistää aivoperäisen 
neurotrofisen tekijän välityksellä vaurioituneiden hermosolujen selviytymistä', Duodecim, vol 125, no. 21. 
E1 Popular contribution to book/other compilations 
2006 
Voipio, J 2006, 'Chloride, Bicarbonate and GABAergic Excitation', Society for Neuroscience 2006 Press Book. 
H1 Patents 
2006 
Airaksinen, M, Lindahl, MS, Timmusk, T, Poteriaev, D, Rossi, J, Saarma, M 2006, Patentti: Compounds related to or derived from 
GFRƒÑ4 and their use, EP 1257581 . 
2007 
Saarma, M, Laurikainen, A, Hiltunen, J, Airaksinen, M, Klinge, E 2007, Neurotrophic factors in the treatment of peripheral nerve 
dysfunction of pelvic area, EP 1 181 042 B1. 
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1 Analysis of activities 2005-2010 
 
- Associated person is one of Carolina Louise Amberg ,  Jaan-Olle Andressoo , Urmas Arumäe , 
 Maxim Bespalov ,  Adrian Goldman , Mohamed Mustafa Mahmoud Helmy , 
 Maili Jakobson ,  Kai Kaila ,  Jukka Kallijärvi , Anmol Kumar , 
Lari Tapio Lehtiö, Maria Susanna Lindahl ,  Päivi Katariina Lindholm ,  Olaya Llano 
Sanchez ,  Anastasia Ludwig ,  Maria Lume ,  Andrzej Lyskowski , 
 Pepin Oliver Launcelot Marshall , Kert Mätlik ,  Liina Nevalaita , 
 Vimal Parkash ,  Anne-Sisko Patana , Martin Puskarjov , 
 Claudio Rivera Baeza ,  Pia Runeberg-Roos ,  Eva Ruusuvuori , 
 Mart Saarma ,  Saurabh Sen, Anastasia Shulga ,  Yulia Sidorova , 
 Sergei Smirnov , Else Tolner ,  Heidi Virtanen , Juha Voipio , 
 Jianmin Yang, Liying Yu ,  Alexey Yukin ,  
 
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 42 
Prizes and awards 11 
Editor of research journal 7 
Peer review of manuscripts 56 
Assessment of candidates for academic posts 10 
Membership or other role in review committee 11 
Membership or other role in research network 11 
Membership or other role in national/international committee, council, board 25 
Membership or other role in public Finnish or international organization 5 
Membership or other role of body in private company/organisation 3 
Participation in interview for written media 6 
Participation in radio programme 2 
Participation in TV programme 2 
Participation in interview for web based media 2 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Adrian Goldman ,  
Supervisor of Doctoral thesis, Adrian Goldman, 2005 
Supervisor of Doctoral thesis, Adrian Goldman, 2005 
Supervisor of Doctoral thesis, Adrian Goldman, 2006 
Supervisor of Doctoral thesis, Adrian Goldman, 2008  … 
Supervisor of Doctoral thesis, Adrian Goldman, 2009 
Supervisor of Doctoral thesis, Adrian Goldman, 2009 
Supervisor of Doctoral thesis, Adrian Goldman, 2009 
Supervisor of Doctoral thesis, Adrian Goldman, 2009 
Kai Kaila ,  
PhD thesis / M. Palva, Kai Kaila, 03.2005, Finland 
PhD thesis supervision / I. Kirilkin, Kai Kaila, 2005  … 
PhD thesis supervision / S. Khirug, Kai Kaila, 2005  2010, Finland 
PhD thesis / S. Sipilä, Kai Kaila, 06.2006, Finland 
PhD thesis / Z. Horn, Kai Kaila, 10.2007  2010, Sweden 
PhD thesis supervision / A. Yukin, Kai Kaila, 2007  … 
PhD thesis / E. Ruusuvuori, Kai Kaila, 11.2008, Finland 
PhD thesis / H. Li, Kai Kaila, 02.2008, Finland 
PhD thesis supervision / F. Ahmad, Kai Kaila, 01.05.2008  2012, Finland 
PhD thesis supervision / A. Tokariev, Kai Kaila, 2009  … 
PhD thesis / T. Viitanen, Kai Kaila, 06.2010, Finland 
PhD thesis supervision / M. Helmy, Kai Kaila, 2010  2013, Finland 
Claudio Rivera Baeza ,  
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2008 
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2008 
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2009  … 
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2010 
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2010  … 
Supervisor of Doctoral thesis, Claudio Rivera Baeza, 2010  … 
Mart Saarma ,  
Co-supervisor of Doctoral thesis, Mart Saarma, 2006 
Supervision of doctoral thesis, Mart Saarma, 2006  …, Finland 
Supervisor of Doctoral thesis, Mart Saarma, 2006 
Co-supervisor of Doctoral thesis, Mart Saarma, 2008 
Supervisor of Doctoral thesis, Mart Saarma, 2008 
Co-supervisor of Doctoral thesis, Mart Saarma, 2009 
Supervisor of Doctoral thesis, Mart Saarma, 2009 
Supervisor of Doctoral thesis, Mart Saarma, 2009 
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Co-supervisor of Doctoral thesis, Mart Saarma, 2010 
Juha Voipio ,  
PhD thesis / J.M. Palva 18.11.2005, Juha Voipio, 2005 
D.Sc.(Tech.) thesis / Pekka Tallgren 15.12.2006, Juha Voipio, 2006, Finland 
PhD thesis / Sampsa Sipilä 16.6.2006, Juha Voipio, 2006 
PhD thesis / Eva Ruusuvuori 28.11.2008, Juha Voipio, 2008 
D.Sc.(Tech.) thesis / Simo Monto 29.4.2010, Juha Voipio, 2010 
PhD thesis / Tero Viitanen 23.6.2010, Juha Voipio, 23.06.2010 
PhD thesis supervisor / M Helmy 2010-2013, Juha Voipio, 2010  2013 
Prizes and awards 
Mohamed Mustafa Mahmoud Helmy ,  
Best Master's thesis in 2009 by the Faculty of Biological and Environmental Sciences, Mohamed Mustafa Mahmoud Helmy, 2009 
Kai Kaila ,  
Academy Professor, Kai Kaila, 1996  2006, Finland 
Viikki Science Park Innovation Prize, Kai Kaila, 2006 
Ella and Georg Ehrnrooth Foundation Honorary Prize, Kai Kaila, 2010, Finland 
Mart Saarma ,  
EMBO member, Mart Saarma, 2005  … 
Karl Schlossmann Science Prize, Mart Saarma, 2005 
Director of the Academy of Finland Centre of Excellence in molecular and integrated neuroscience research, Mart Saarma, 2008  
2013 
Academy Professor, Mart Saarma, 2009  2013 
The Lundbeck Foundation Nordic Research Prize, Mart Saarma, 2009 
Medal of the Faculty of Medicine, University of Tartu, Mart Saarma, 2010 
Else Tolner ,  
C-WIN Postdoctoral travel award 2009, Else Tolner, 07.2009, United States 
Editor of research journal 
Adrian Goldman ,  
Protein Engineering, Design and Selection, Adrian Goldman, 01.01.2003  …, United Kingdom 
Biochemistry, Adrian Goldman, 01.01.2007  31.12.2007 
Science, Adrian Goldman, 01.01.2007  31.12.2007 
Structure, Adrian Goldman, 01.01.2007  31.12.2007 
Biochemistry, Adrian Goldman, 01.01.2008  31.12.2008, United States 
PNAS, Adrian Goldman, 01.01.2008  31.12.2008, United States 
Mart Saarma ,  
Member of the Editorial Board, Experimental Neurology, Mart Saarma, 2005  2010 
Peer review of manuscripts 
Urmas Arumäe ,  
Reviewer, Cell Death and Differentiation, Urmas Arumäe, 2007 
Reviewer, Cell Tissue Res, Urmas Arumäe, 2007 
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Reviewer, J. Neurosci. Meth, Urmas Arumäe, 2007 
Reviewer, Eur. J Pharmac. Sci, Urmas Arumäe, 2008 
Reviewer, Eur. J. Biochem, Urmas Arumäe, 2009 
Reviewer, Eur. J. Cell Biol, Urmas Arumäe, 2009 
Reviewer, Exp Cell Res, Urmas Arumäe, 2009 
Reviewer, Neuropharmacology, Urmas Arumäe, 2009 
Reviewer, Neuroscience, Urmas Arumäe, 2009 
Reviewer, J. Neurochem, Urmas Arumäe, 2010 
Reviewer, J. Neurosci, Urmas Arumäe, 2010 
Reviewer, Neurochem. Res, Urmas Arumäe, 2010 
Adrian Goldman ,  
Acta Crystallographica section D, Adrian Goldman, 01.01.2002  …, United States 
Acta Crystallographica section D, section F, Adrian Goldman, 2004  … 
Kai Kaila ,  
Reviewer / Journal of Neurophysiology, Kai Kaila, 1992  … 
Reviewer / NeuroImage, Kai Kaila, 1995  … 
Reviewer / Neuroscience, Kai Kaila, 1996  … 
Reviewer / Brain, Kai Kaila, 1998  … 
Reviewer / Amer. J. Physiology, Kai Kaila, 2000  … 
Reviewer / European Journal of Neuroscience, Kai Kaila, 2004  … 
Reviewer / Journal of Neuroscience, Kai Kaila, 2004  …, United States 
Reviewer / Journal of Physiology, Kai Kaila, 2004  … 
Reviewer / Neurobiology of Disease, Kai Kaila, 2004  … 
Reviewer / Neuropharmacology, Kai Kaila, 2004  … 
Reviewer / Bioorganic &amp; Medicinal Chemistry, Kai Kaila, 2005  … 
Reviewer / Cerebral Cortex, Kai Kaila, 2006  … 
Reviewer / Trends in Neurosciences, Kai Kaila, 2006  … 
Reviewer / Epilepsia, Kai Kaila, 2008  … 
Reviewer / Neuron, Kai Kaila, 2008  … 
Reviewer / Annals of Neurology, Kai Kaila, 2009  … 
Reviewer / Nature Clinical Practice, Kai Kaila, 2009  … 
Reviewer / Nature Medicine, Kai Kaila, 2009  … 
Reviewer / Nature Reviews Neurology, Kai Kaila, 2010  … 
Claudio Rivera Baeza ,  
Referee, Biochem. Biophys. Acta, Claudio Rivera Baeza, 2005  2010 
Referee, Brain Research, Claudio Rivera Baeza, 2005  2010 
Referee, European Journal of Neuroscinece, Claudio Rivera Baeza, 2005  2010 
Referee, J. Comp. Neurol, Claudio Rivera Baeza, 2005  2010 
Referee, Journal of Neuroscience, Claudio Rivera Baeza, 2005  2010 
Referee, Nat. Neuroscience, Claudio Rivera Baeza, 2005  2010 
Referee, Neurochemistry, Claudio Rivera Baeza, 2005  2010 
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Referee, Trends in Neuropharmacology, Claudio Rivera Baeza, 2005  2010 
Referee, Trends in Neuroscience, Claudio Rivera Baeza, 2005  2010 
Eva Ruusuvuori ,  
Reviewer for Glia, Eva Ruusuvuori, 2010 
Reviewer for Neuroscience, Eva Ruusuvuori, 2010 
Reviewer for The Journal of Neuroscience, Eva Ruusuvuori, 2010 
Mart Saarma ,  
Reviewer, Experimental Neurology, Mart Saarma, 2005  2010 
Reviewer, Molecular Biology, Mart Saarma, 2005  2010 
Reviewer, Molecular Biology, Mart Saarma, 2005  2010 
Juha Voipio ,  
Acta Physiologica, peer review, Juha Voipio, 2006 
Aquatic Toxicology, peer review, Juha Voipio, 2006 
Brain Research Bulletin, peer review, Juha Voipio, 2006 
Journal of Neuroscience Research, peer review, Juha Voipio, 2006 
Journal of Neurophysiology, peer review, Juha Voipio, 2007 
IEEE Transactions on Neural Systems &amp; Rehabilitating Engineering, peer review, Juha Voipio, 2009 
Journal of Neuroscience Methods, peer review, Juha Voipio, 2009 
Journal of Neuroscience, peer review, Juha Voipio, 2010 
Assessment of candidates for academic posts 
Adrian Goldman ,  
Assessment of candidate for academic post, Adrian Goldman, 2005 
Assessment of candidate for academic post, Adrian Goldman, 2007 
Assessment of candidate for academic post, Adrian Goldman, 2008 
Assessment of candidate for academic post, Adrian Goldman, 2010 
Kai Kaila ,  
Promotion to professor, Univ. California, Davis, Kai Kaila, 2005, United States 
Gottfried Wilhelm Leibniz Prize, Kai Kaila, 2006, Germany 
Professor in General Neurophysiology, Univ. Heidelberg, Kai Kaila, 2008, Germany 
Promotion to professor, Univ. College London, Kai Kaila, 2008, United Kingdom 
ERC-2009-Advanced Grants, ERC European Research Council Executive Agency, Kai Kaila, 2009 
Promotion to professor, Univ. Oslo, Kai Kaila, 2009, Norway 
Membership or other role in review committee 
Adrian Goldman ,  
Reviewer of research grant, ERA-NET, Adrian Goldman, 2005  2010 
Reviewer of research grant, EU, Adrian Goldman, 2005  2010 
Reviewer of research grant, Israel Research Foundation, Adrian Goldman, 2005  2010 
Reviewer of research grant, NSF, Adrian Goldman, 2005  2010 
Reviewer of research grant, Norwegian Research Foundation, Adrian Goldman, 2005  2010 
Reviewer of research grant, Wellcome Trust, Adrian Goldman, 2005  2010 
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Kai Kaila ,  
Research Council of Norway, Kai Kaila, 1996  …, Norway 
Academy of Finland, Kai Kaila, 17.02.2005 
Reviewer / French National Research Agency (ANR), Kai Kaila, 2006  …, France 
Reviewer / European Research Council Executive Agency (ERCEA), Kai Kaila, 2008  … 
Reviewer / European Science Foundation (ESF), Kai Kaila, 2008  … 
Membership or other role in research network 
Adrian Goldman ,  
Member of Biocentrum Helsinki, Adrian Goldman, 2005  2008 
Kai Kaila ,  
Member of the Academy of Finland CoE in Molecular Neurobiology, Kai Kaila, 1999  2005 
Fellow of the Biocentrum Helsinki Organization, Kai Kaila, 2004  2013 
Member of Nordic CoE for Research in Water Imbalance Related Disorders, Kai Kaila, 2005  2009 
Cortex Training Network (Marie Curie EST), Kai Kaila, 01.01.2006  31.12.2009 
EU FP6 Integrated project EPICURE, Kai Kaila, 2007  2011 
Member of the Finnish CoE in Molecular and Integrative Neuroscience Research, Kai Kaila, 2008  2013, Finland 
Nordic-Russian postgraduate training network in neuroscience, Kai Kaila, 2009  2010 
Claudio Rivera Baeza ,  
Member of American Neuroscience Society, Claudio Rivera Baeza, 1996  … 
Member of FENS, Claudio Rivera Baeza, 2000  … 
Member of Biocentrum Helsinki, Claudio Rivera Baeza, 2001  2010 
Membership or other role in national/international committee, council, board 
Adrian Goldman ,  
Board member, Informational and Structural Biology Graduate school, Adrian Goldman, 2003  2005 
Nordic Research Council, Adrian Goldman, 01.01.2007  31.12.2007, Norway 
Board member of Viikki campus animal experimentation/non-clinical trials ethics committee, Adrian Goldman, 2008  2010 
Board member, Informational and Structural Biology Graduate school, Adrian Goldman, 2008  … 
Cochair of the structural biology board of Biocenter Finland, Adrian Goldman, 2008  … 
International Network of Protein Engineering Centres, Adrian Goldman, 01.01.2008  31.12.2008 
Kai Kaila ,  
Reviewer / Swedish Natural Science Research Council, Kai Kaila, 1996  …, Sweden 
Finnish Graduate School of Neuroscience (FGSN), Kai Kaila, 1998  2011, Finland 
Reviewer / National Health and Medical Research Council (Australia), Kai Kaila, 1998  …, Australia 
Reviewer / Israel Science Foundation, Kai Kaila, 1999  …, Israel 
Reviewer / Wellcome Trust, Kai Kaila, 2000  …, United Kingdom 
Reviewer / Biotechnology and Biological Sciences Research Council (UK), Kai Kaila, 2001  …, United Kingdom 
Reviewer / Deutsche Forschungsgemeinschaft (SFB evaluations), Kai Kaila, 2004  …, Germany 
Finnish Graduate School of Neuroscience, Kai Kaila, 01.01.2006  31.12.2006 
Institute of Biotechnology, University of Helsinki - Member of the Executive Committee, Kai Kaila, 2008  … 
Chairman/coordinator/grant holder of EACEA Tempus project, Kai Kaila, 14.01.2010  13.01.2013 
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Mart Saarma ,  
Chairman of the Scientific Advisory Board of the Heidelberg Neuroscience Center, Mart Saarma, 2005  2010 
Chairman of the board of the Directors of the National Institute of Chemical Physics, Mart Saarma, 2005  2009 
Council member of Estonian PMs Council for Science and Technology, Mart Saarma, 2005  2010 
Member of Scientific Advisory Board of the Gottingen Neuroscience Centre, Mart Saarma, 2005  2010 
Member of the Scientific Advisory Board of the Helsinki Institute of Information Technology, Mart Saarma, 2005  2010 
Member of the Estonian President Academic Council, Mart Saarma, 2007  2010 
Member of the Scientific Advisory Board of the Estonian Cancer Competence Centre, Mart Saarma, 2007  2010 
Director &amp; Chairman of the board of Biocenter Finland, Mart Saarma, 2008  2009 
Member of EMBO Council, Mart Saarma, 2010  … 
Membership or other role in public Finnish or international organization 
Kai Kaila ,  
Member of Societas Scientiarum Fennica (Suomalainen Tiedeakatemia), Kai Kaila, 2001  … 
Member of Academia Scientiarum Fennica, Kai Kaila, 2004  …, Finland 
Committee for research affairs, Kai Kaila, 2008  2013 
AVARA-varainhankintakampanja, Kai Kaila, 2009  … 
Claudio Rivera Baeza ,  
Member of Finnish Brain Research Society, Claudio Rivera Baeza, 2000  … 
Membership or other role of body in private company/organisation 
Mart Saarma ,  
Member of Board of the Directors, Mobidiag Ltd, Mart Saarma, 2005  2009 
Member of the scientific advisory board, Neurotrophics Inc, Mart Saarma, 2005  2009 
Chairman of the Board of Directors, HermoPharma Ltd, Mart Saarma, 2008 
Participation in interview for written media 
Kai Kaila ,  
Interview, Kai Kaila, 04.2009, Finland 
Interview / Ihminen on biologinen kone, Kai Kaila, 09.2009, Finland 
Claudio Rivera Baeza ,  
Claudio Rivera’s research group discovered how the development of nerve connections is synchronised. But who is Rivera? ,HUB, 
Claudio Rivera Baeza, 2008 
Helsingin Yliopisto Tiedelehti, Claudio Rivera Baeza, 01.01.2008  31.12.2011, Germany 
Helsinki University WebPages, Claudio Rivera Baeza, 01.01.2008  31.12.2011, Germany 
Vaurioituneet hermosolut saavat kehityksenaikaisia ominaisuuksia, Duodecim, Claudio Rivera Baeza, 2008 
Participation in radio programme 
Kai Kaila ,  
YLE Terveys, Radion tiedeuutiset, Kai Kaila, 05.10.2006 
Participation in radio programme, Kai Kaila, 12.02.2009 
Participation in TV programme 
Kai Kaila ,  
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Interview: YLE Teema, Kai Kaila, 2005 
Mart Saarma ,  
TV movie: Püramiidi tipus (At the tope of the pyramid), Estonian TV, Mart Saarma, 2010 
Participation in interview for web based media 
Kai Kaila ,  
Tieteessä tapahtuu: Neurobiologia – Silta fysiikasta psykologiaan, Kai Kaila, 2006 
Keskosen ensimmäinen myssy mittaa aivojen toimintoja, Kai Kaila, 10.11.2010, Finland 
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Saarma M 
Basic statistics 
Number of publications (P) 135 
Number of citations (TCS) 1,416 
Number of citations per publication (MCS)  10.54 
Percentage of uncited publications 16% 
Field-normalized number of citations per publication (MNCS)   1.26 
Field-normalized average journal impact (MNJS)   1.48 
Field-normalized proportion highly cited publications (top 10%)   1.55 
Internal coverage    .94 
 
Trend analyses 
 
MNCS 
 
THCP10 
 
MNJS 
Collaboration 
 
Performance (MNCS) by collaboration type 
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